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PREFACE
Enzymes propagate an amazing array of chemical reactions. Enzymatic prowess
in propagating and controlling reactions involving carbon-carbon bond cleavage, radi-
cals, or the stabilization of high-energy transition states are of particular interest, as it
is often the case that synthetic chemistry can not recapitulate these types of reactions,
at least without multiple chemical steps, caustic solvents, the creation of toxic waste
products and a significant investment in manpower. Therefore, understanding how
enzymes mechanistically control these difficult reactions, particularly those enzymes
that utilize metals cofactors, not only contributes to fundamental understanding of
bioinorganic chemistry, but also allows for new avenues of enzyme assisted product
synthesis of stereospecific products.
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Kellett, Whitney F. PhD, Purdue University, December 2014. How Do Metalloen-
zymes Propagate and Control Chemical Reactions?. Major Professor: Nigel G. J.
Richards.
Enzymes control and propagate a dizzying array of chemical reactions, includ-
ing radical reactions and reactions cleaving carbon-carbon bonds. Metalloenzymes,
which contain a metal cofactor, are particularly adept at propagating these reactions.
This thesis focuses on several metalloenzymes; each an example of a different unique
reaction control strategy. Both experimental and computational methodologies have
been employed in order to identify specific residues or features which contribute to
each enzyme’s ability to control the reaction. Emphasis is made on special properties
of the metal Manganese. Controlling residues include not only first shell or active site
residues, but also residues more distant from the active-site. Further, manipulation
of such residues can be used to alter reactivity at ”non”-active-sites, or to alter the
apparent electrostatics of the protein (in the case of substitution of hydrogen with
fluorine). Electron Paramagnetic Resonance (EPR) and other forms of magnetic
spectroscopy can be used to evaluate subtle differences imposed by substitution for
controlling residues to a metal center, which gives further insight into the electronic
contributions of given residues, as well as the electronic properties of metal cofactors.
In summary, the catalysis by Mn-dependent and other metal-dependent metalloen-
zymes can be investigated through multiple kinetic and spectroscopic avenues, un-
veiling suprising and novel themes in enzymatic catalysis, such as mechano-chemical
switches and super long-distance metallo-interactions.
11. Introduction
In this thesis, I introduce three unique enzymes which use local and long-range strate-
gies to propagate difficult chemical reactions. Each enzyme occupies a chapter, and
at the conclusion of each chapter is a .PDF file of the original paper which eminated
the described efforts. Figures 1.1, 1.2 and 1.3 preview graphically the major point
of each chapter moving forward. Although this does not comprise all of the work
that has been completed during this PhD, it is a concise and connected presentation
of projects which all shared similar techniques and goal strategies, and are all mar-
ried by the same theme of understanding how enzymes propagate difficult reactions.
Chapter two opens with an example where we used our understanding of decarboxyla-
tion reactions to spot a mis-assigned ”novel decarboxylase”. Chapter three continues
with efforts to probe the possibility of a catalytic switch in a B12 dependent mu-
tase, with additional work in engineering this enzyme to process novel substrates into
commercially interesting products. Chapter four continues with experiments aimed
at understanding fundamental unknowns, and in solving controversy surrounding the
enzyme Oxalate Decarboxylase. Chapter five is unique from other chapters in that it
probes a data-driven direction forward on the Oxalate Decarboxylase project.
2Figure 1.1. Chapter 2 - Is Frsa a Pyruvate Decarboxylase?
3Figure 1.2. Chapter 3 - Mechanistic Studies and Enzyme Engineering
on the enzyme Methylmalonyl-CoA Mutase
4Figure 1.3. Chapter 4 - Short- and Long-Range Control Strategies in
the enzyme Oxalate Decarboxylase
5Figure 1.4. Chapter 5 - Future Directions
6
72. Fermentation-Respiration Switch Protein from V ibrio vulnificus is not a
Decarboxylase
Much recent attention has been afforded to the understanding of reactions which
cleave stable and otherwise unreactive carbon-carbon bonds. [1, 2] It is clear that
carbon-carbon bond cleavage reactions are energetically expensive, and thus enzy-
matic cleavage of these bonds is of interest, especially by metal cofactors. In addition
to questions in chemistry, many carbon-carbon bond cleavage reactions are of great
industrial interest, for example, in the degradation of biomass for the production of
fuels. [3] Not only can these investigations streamline production of carbon-carbon
bond cleaved products, but may afford new avenues for enzyme-based industry chem-
istry.
2.1 Introduction
FrsA was reported to be a new cofactor-independent pyruvate decarboxylase in
2011 [4] with massive implications for enzymatic decarboxylation reactions as well as
carbon-carbon bond cleavage reactions in general. This chapter chonicles the experi-
mental and computational efforts that were employed to understand the mechanism
of this novel reaction. During the course of the experimental work, it was discovered
that FrsA actually showed no decarboxylase activity in our hands or the hands of
the Almo group. This stance was supported by computational efforts, and we then
published a paper with this data, attesting that the original functional annotation of
FrsA was made in error.
8Figure 2.1. The reaction proposed to be catalyzed by FrsA; Pyruvate
is decarboxylated via an acyl anion intermediate to form acetaldehyde
and carbon dioxide. (Used with permission) permission [9])
This was an important contribution because of the impact of the original pa-
per, which threw into sharp question many evolutionary claims about the impor-
tance/necessity of the thiamine cofactor in enzymatic pyruvate decarboxylation re-
actions [5–7] as well as the importance of specific interactions and possibly allostery
in OMPDC [8].
The putative pyruvate decarboxylase FrsA, which binds to IIAGlc in vivo was re-
ported to catalyze the conversion of pyruvate into acetaldehyde and carbon dioxide,
as shown in Figure 1.1. This reactive acyl anion intermediate was reported to be
stabilized by an orotidine 5’-monophosphate decarboxylase (OMPDC) [8] like mecha-
nism, but this seemed unlikely based on the crystal structure pose, the relative small
size of the substrate (which precludes it from many of the stabilizing features found
in OMPDC substrates which are typically much larger), and finally the divergence
of the fold (both sequence and structure) of the FrsA protein compared to OMPDC
(and thus the implied lack of evolutionary relationship between the two proteins [10].)
Experimental and computational efforts were used to respectively assay this reaction
in vitro and study the energetics of carbon-carbon cleavage of the pyruvate molecule
in the proposed FrsA active site.
2.1.1 Fermentation-Respiration Switch and Glycolysis
The crr gene product (IIAGlc) mediates the transport of a variety of sugars as
part of the bacterial phosphoenolspyruvate(PEP):sugar phosphotransferase system
(PTS). Specifically, the PTS energetically links phosphorylation events with tran-
9solocation events of these sugar substrates across the cytoplasmic membrane. Many
cytoplasmic soluble proteins and one-membrane bound protein make up the PTS. El
and HPr (histidine phosphocarrier protein) are universal to all sugars, whereas IIAGlc
and IIBGlc (membrane-bound) are sugar specific. Therefore, glucose uptake requires
sequential phosphoryl transfer along the PTS system as shown in Schematic 2.1:
PEP → El→ HPr → IIAGlc → IIBGlc → glucose (2.1)
There are other roles, usually regulatory, that various members of this PTS ”chain”
are involved with, notably in the control of glycerol kinase and adenylyl cyclase. An
interesting fact for the purposes of this chapter, is that the ratio of IIAGlc phospho-
rolyated to IIAGlc dephoshporylated is related to the ratio of PEP to pyruvate in the
cell (Equation 2.2), although a mechanism by which this is satisfied is not known. [11]











2.1.2 FrsA interacts with and affects IIAGlc
FrsA was discovered in a pool of proteins found to bind to E. Coli IIAGlc,
more tightly than any other known protein, and was thus dubbed the ”fermenta-
tion/respiration switch protein”. FrsA is a 47 kDa protein, which is soluble and
complexes with the unphosphorylated form of the protein IIAGlc. FrsA has biological
effects in vivo - specifically, in FrsA gene knock-out cells, cellular respiration was in-
creased, and when FrsA was over-expressed, cellular fermentation was increased. This
behavior was sugar dependent, and FrsA is thus proposed to regulate the fermenta-
tion/respiration ”switch” by communicating available sugar substrates to IIAGlc via
a phosphorylation event. [12]
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Figure 2.2. Thiamine Diphosphate Cofactor
2.1.3 FrsA is classified as Pyruvate Decarboxylase Enzyme
In addition to the role proposed for FrsA as a IIAGlc reporting switch, FrsA was
said to, as purified alone with no other proteins or binding partners, be classified as a
pyruvate decarboxylase. Specifically, pyruvate is said to be converted to acetaldehyde
and carbon dioxide by FrsA, in a reaction shown in figure 2.1. Kinetic data support
this finding, suggesting that the rate for decarboxylation is over 3500 kcat/KM (two
orders of magnitude faster than yeast PDC). Crystal structures support this find in
that they show a single FrsA molecule, but they lack substrate bound in the active
site and show no obvious means of allostery.
2.1.4 Known Pyruvate Decarboxylation Reactions
In order to understand the gravity of the claim that FrsA can be a pyruvate
decarboxylase, it is necessary to understand the two documented enzymatic routes
to pyruvate decarboxylation. First discussed is the thiamine dependent pyruvate
decarboxylases, and next are decarboxylases which depend on electrostatic repulsion
in the active site. The latter is the general proposed mechanism for FrsA.
Thiamine diphosphate (ThDP)-Dependent Reactions
Some of the earliest discovered enzymes, ThDP-dependent enzymes cleave carbon
bonds, notably carbon-carbon bonds. [13, 14] ThDP enzymes fulfill multiple roles as
tranketolases, oxidoreductases, 2-ketoacid dehydrogenases and finally decarboxylases.
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All ThDP-dependent enzymes have conserved ThDP-binding specific domains, the
PP (pyrophosphate) domain and the PYR (pyrimidine) domain. Specifically, the
ThDP-dependent pyruvate decarboxylases catalyze the non-oxidative decarboxylation
of pyruvate to acetaldehyde. The active form of this enzyme is is both ThDP (Figure
2.2) and Mg2+ dependent. The necessary binding domains for ThDP were recruited
multiple times with no common-ancestor, i.e. nature re-invented the ThDP ”wheel”
through domain linkage, rerrangement and recruitment, several unique times. [15,16]
Electrostatic Repulsion Dependent Reactions
So called cofactorless enzymatic decarboxylation reactions have emerged in recent
years, some with activities orders of magnitude more active than the ThDP-depedent
decarboxylases. The potential for cofactor-free decarboxylation is exciting, however,
the active sites of such enzymes must be specifically tuned to allow this difficult
chemistry to occur. The active site must destabilize the carboxylic substrate. This
is accomplished through electrostatic ground-state destabilization, sometimes called
”electrostatic stress”. In this case of the most well studied enzyme of this class,
Orotidine-5’-monophosphate decarboxylase (OMPDC), overall favorable electrostat-
ics allow for substrate entry into the active site, where an aspartate clashes with
the carboxyl group and an hydrogen bond network is in place to stabilize the vinyl
intermediate. [17, 18] In addition to this electrostatic network of interactions, an ac-
tive site loop closes over the OMP binding site upon binding of substrate. [19] This
conformational change further exacerbates the electrostatic repulsion in the substrate-
loaded active site environment. It is proposed that without this loop movement, the
substrate would not be able to enter such a ”hostile” active site. [20]
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2.2 Results
2.2.1 Expression of FrsA protein
Experimental efforts were focused towards replicating the originally reported as-
says. This involved the expression and purification of the enzyme as originally re-
ported. [4] The protein was not found to be active using Membrane-Inlet Mass Spec-
trometry, a method that has been developed specifically for the detection of carbon
dioxide (CO2) in biological systems. [21] Interestingly, this apparently inactive protein
was successfully crystallized and a 1.9 A˚ structure was obtained (through collabora-
tion with the Almo group). Also surprisingly, the structure was crystallized with
hexanoic acid (Figure 2.3), assumed to be endogenous from the original cellular envi-
ronment as it was not added during crystallization. Subsequent attempts to discover
any decarboxylation activity of this protein continued to fail, thus it was not possible
to validate the kinetic parameters as reported in the original paper. This was also
verified independently by the Almo group with the same results.
2.2.2 Molecular Dynamics of FrsA in complex with Pyruvate
The originally reported structure (PDB accession number 3MVE) was modified to
include hydrogens, TIP3P water molecules [22], and chloride ions (to neutralize the
system). Then, several methods were used to ensure that pyruvate could be docked
in as many possible reasonable conformations as possible. These three methods are
explained below.
Pyruvate docked using GLIDE
Subsequent relaxation and equilibration of the system was conducted via MD
simulation, using standard methods [23]. Briefly GAFF [24] based parameterization
of Pyruvate was performed using the ANTECHAMBER [25] module of AMBERTools,
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Figure 2.3. FrsA crystal structure with hexanoic acid in the active site. [9]
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Figure 2.4. Putative FrsA substrate pyruvate molecule with selected parameters
from a molecule of pyruvate constructed from standard bond, angle and dihedral
values. [26]
Pyruvate was docked, using GLIDE, into the protein active site (only one docking
conformation was located). Equilibration was further conducted from this pose, with
constraints being systematically removed from the pyruvate, and 50 ns of simulation
was conducted.
GLIDE generated structure used to sample other similar structures
From the GLIDE discovered structure, pyruvate was manually manipulated along
three axes to produce eight different poses of pyruvate in the active site. After 10 ns
of equilibration, each of these poses was essentially identical to the GLIDE discovered
pose.
Multiple copies of pyruvate replicated in active site to further explore
active site space (Madrox Sampling)
Because the active site did seem large for the substrate, it was a concern that
the area of the pocket discovered by GLIDE might not to be the only binding area
for pyruvate. The previous method repositioned the substrate within a given area,
15
Figure 2.5. Eight starting poses of pyruvate generated by rotation
along various bond axes (stick and ball represenation) as well as sev-
eral active site residues (”licorice” representation).
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Figure 2.6. Eight poses of pyruvate generated by Madrox Sampling.
Pyruvate is shown in purple.
but it did not force the substrate to explore other regions of the pocket. In order
to force the substrate to leave the pocket, an MD simulation was run where the
eight poses of pyruvate were all placed in the active site simultaneously. Strong
restraints (50 kcal/mol) were placed on the protein to prevent the structure from being
compromised. The pyruvate molecules immediatly experienced extreme energies and
inhabited all imaginable surface areas inside the active site. Each of these new poses
was then minimized. In cases where pyruvate has essentially left the active site, (two
poses), pyruvate travels to solvent upon equilibration. In the other six poses, pyruvate
eventually occupied the original GLIDE-determined binding site. The implications
of the creation of this method of sampling, which we call ”Madrox Sampling”, are
discussed later in this chapter.
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2.2.3 Car-Parrinello Molecular Dynamics of the Pyruvate Carbon-Carbon
bond Cleavage Reaction
CPMD calculations were carried out upon being assured that the originally deter-
mined GLIDE binding site and binding conformation was indeed reasonable. Pyru-
vate, the Tyr-316 side chain, and the three waters closest to pyruvate were included
in the QM region and described with the BLYP functional norm-conserving Martins-
Trouiller pseudopotentials [27] with dispersion-corrected atom-centered dispersion po-
tentials. All other atoms, including waters, are described with the classical AMBER99
force field [28]. The carbon-carbon bond length is designated as the fictitious reaction
coordinate. Sampling was conducted using standard methods, and the free energy
profile generated by thermodynamic integration (integration of the contraint force as
a function of fictious bond carbon-carbon bond length). The energy barrier obtained
approaches the experimental value for pyruvate decarboxylation in water (without the
assist of a protein sidechain), which suggests that the protein, in this binding mode,
offers no additional assistance to the reaction in the form of lowering the energy
barrier.
2.3 Conclusion
Experimental and computational evidence suggests that FrsA can not be a pyru-
vate decarboxylase. This protein simply lacks the mechanistic features that would
support this hypothesis.
There are several critiques of the necessary assumptions that were made in these
experiments. First, the CPMD calculations are dependent on the starting geometry of
a non-crystallographic (computationally determined) active site water. If this water
placement is incorrect, this may effect the outcome and thes resultant energy as the
organization of these waters is likely critical.
Second, it is possible, especially given the claims of very difficult assay conditions,
that this protein is simply too unstable to measure activity using MIMS, although this
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Figure 2.7. CPMD/MD/TI generated trajectory of the cleavage of
the C-C bond in pyruvate. Poses and the Energy Barrier Profile, as
a function of C-C bond cleavage, are shown.
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claim is combatted by the fact that the original assays were attempted unsuccessfully
by two independent enzyme kinetics groups.
Finally, this protein in solution may complex with another protein (in fact, it it
has very strong affinity for another protein IIAGlc, and this complex may support
activity or cause allosteric or other regulation in FrsA that alters it’s activity and the
conformation of the very active site itself. The original paper reports a gel filtration
step to ensure that no other protein is purified along with FrsA for the assays, so there
is no reason to believe that this explains the activity in the original assays. Further,
the crystal structure from the original paper as well as from our studies confirms that
FrsA has been purified as and is at least stable in monomeric form. Both evidence that
any activity in the original paper can not be explained by the carryover of another
protein bound from the original prep. Since the conclusion of this work, a patent by
the original group has been filed for the crystallization conditions of the FrsA protein
bound to the IIAGlc-coding gene, a complex which is reported to have activity as a
pyruvate decarboxylase (Figure 2.8). No follow-up has been made on this claim.
The function of the FrsA protein alone, outside of it’s general signaling role in
transmembrane glucose transport, is currently unknown. The α/β hydrolase fold of
proteins, the superfamily to which FrsA belongs, is quite functionally diverse, and
includes proteins with not only hydrolase function but also lyase and transferase
activities, and serving in cellular functions as transporters and chaperones, amongst
other functions. From homology alone, it is impossible to predict function of this
protein. The presence of hexanoic acid in the active site of the crystallized protein
(Figure 2.3) suggests that this protein may play a role in fatty acid metabolism,
although we have no evidence to support this claim.
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Figure 2.8. Frsa (multi-colored) in complex with IIAGlc (pink), from




Methods for protein production, both with input form the original authors of the
paper [4], were conducted in two stages. Initially, the originally reported methods
were followed. After these methods did not produce active protein (although the
protein was quite stable), the original authors were contacted at which point they
supplied a different set of methods. These protein preparation methods were also
unsuccessful in producing active protein in my hands.
Original Protein Production Protocol
The plasmid containing FrsA was generously provided by the authors of the orig-
inal paper. This plasmid was overexpressed in E. coli JM109 by adding 200 µM
IPTG, and purified using Ni2+-NTA affinity chromatography. Expression in JM109
is a non-standard cell type for protein expression, but is possible as long as the F’
episome on the plasmid is conserved.
Ammended Protein Production Protocol
It was noted by the original authors, in subsequent correspondance that FrsA
activity is abolished by freezing and thawing, even in 50% glycerol and thus FrsA
should be used directly after purification. Additionally, the authors provided more
specific expression and purification protocol procedures, outlined here.
A non-commercial plasmid construct containing the gene encoding FrsA was over-
expressed in E. Coli JM109 cells growing in Low-salt Luria broth in the presence of
0.2mM IPTG for 2 hr at 37◦C. Cells were pelleted and 5 mL of lysis buffer per 100 mL
of culture was used to dissolve the pellet. In order to resuspend the pellet, cells were
sonicated on ice, and the lysate centrifuged at 10,000 xg at 4◦C for 20 min. For every
100 mL of culture, 100 µl of Ni2+-NTA resin was added and loaded onto a disposable
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column. The column was washed twice each with buffer containinng 10 mM and 20
mM imidizaole concentrations. Elute 100 µl of protein for every 100 mL of original
culture, and either assay directly or confirm size using SDS-PAGE and purify further
with a Superdex HR 16/60 gel filtration column. Purification buffer compositions are
found in Table 2.1 below. [9]
Table 2.1.
FrsA Purification Buffer Compositions
Buffer NaH2PO4 Conc. NaCl Conc. Imid. Conc. DTT conc.
Lysis 50 mM, pH 8.0 300 mM 0 mM 0 mM
Wash 50 mM, pH 8.0 300 mM 10/20 mM 0 mM
Elution 50 mM, pH 8.0 300 mM 250 mM 0 mM
Size Exc. 50 mM, pH 8.0 300 mM 0 mM 1 mM
2.4.2 Assays
Ca(OH)2 assay
These assay conditions were supplied by the original authors [4]. The addition
of Ca(OH)2 to a solution containing your FrsA protein and pyruvate will induce the
following reaction only when FrsA produces CO2 (Equation 3.1). This precipitate is
visible to the naked eye (or at OD600) as a quick assay to see if the enzyme is active.
Ca(OH)2 + CO2 → CaCO3 (2.3)
No visible precipitate, nor an change in absorbance was noted upon the addition





Total Volume 1 mL
Reaction Temp. 20◦C
Buffer 10 mM Tris
Buffer pH 7.5
Additive 1 mM DTT
Pyruvate Final Conc. 2 mM
Ca(OH)2 Final Conc. 2 mM
Membrane Inlet Mass Spectrometry (MIMS)
Membrane Inlet Mass Spectrometry (MIMS) incorporates a permeable membrane
into a mass spectrometer to detect small, uncharged molecules in both continous
and endpoint applications. This has been a particularly useful method to determine
the production of CO2 (or
13CO2 from
13C-labeled substrate) during the catalytic
reactions governed by enzymatic decarboxylases. [21] Despite the lack of success of
the initial Ca(OH)2 assay, MIMS evolution of CO2 was measured under a variety of
different conditions, buffers, pHs, enzyme concentrations and substrate concentration,
with no evidence of CO2 evolution. [9]
2.4.3 Classical Molecular Dynamics (MD)
Introduction to Classical Molecular Mechanics
Biological molecules, such as enzyme:substrate complexes exhibit very fast (fem-
tosecond and slower) local motions (sidechain motion and some loop motions) as
well as slow (microsecond and slower) large-scale motions (folding/unfolding, associ-
ation/dissassociation, large allosteric changes), and additionally some motions which
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may occur at various time scales depending on the size of the region in question (do-
main or subunit motion, to include large loop motions). Molecular Dynamics is an
almost 60-year-old method used to generate predictive information about these mo-
tions, which can support and extend upon experimental observations about biological
systems.
Many excellent review articles are available regarding molecular dynamics as ap-
plied to biological systems [29]. Classical Molecular Mechanics (MM, an implimen-
tation of which is MD), is a relatively fast way to accomplish molecular modeling of
large systems. It is limited in that it is less accurate than methods which incorporate
quantum mechanics, as it is based in principles in Newtonian Mechanics. Thus, elec-
tronic phenomena, such as bond-making or bond-breaking, are necessarily excluded
from MM (and therefore MD) simulations. Molecular Dynamics is govererned by
classical statistical mechanics, implemented via atomic degrees of freedom (MD is
”atom centered”) and described by the equations of motion from classical (Newto-
nian) dynamics. Relevant to the problem of determining a FrsA:pyruvate complex in
particular, complexation (formation of enzyme:substrate complexes) can be modeled
with Molecular Dynamics as this phenomena is governed by weak, non-bonding forces
as a function of thermodynamic equilibria.
The Classical Force Field
If MM (and MD) are centered on atomic degrees of freedom, and Newtonian equa-
tions are used to describe the interactions between atoms, the most basic relationship
between two elementary particles (atoms) is a bond length, or a distance between par-
ticle A and B. Likewise, an angle between three particles A, B and C, and a dihedral
angle between particles A, B, C and D can be defined. Classical Force Fields, based
on an atom type of varying degrees of specificity, define a potential energy function
V (r), for which the values are generated from quantum mechanical or experimental
data: in the case of the AMBER force field, experimental free energies are generally
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used to paramaterize various atom types. This means that usual bond lengths, an-
gle and/or dihedral value for a given arrangment of atoms, according to a perceived
bonding pattern which based on atomic distances, are experienced in the course of
a simulation. The form of each of these forces varies upon the nature of interaction
(bonds are classically harmonic, where as a dihedral angle must be necessarily pe-
riodic). The force field is organized such that various atom types are available for
manipulation. Otherwise, the oxygen in a carbonyl group is differentiated from an
oxygen in an alcohol by inclusion in separate atom types. There are many available
force fields with varying strengths and weaknesses. The AMBER99 force field (2.4)
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Explicit Solvation and Boundary Conditions
In these models, explicit water molecules are added to the peripherary of the
protein in order to simulate bulk water, or the protein or protein complex in solution.
The water model used is TIP3P, a simple yet robust three mode water molecule which
was chosen due to the fact that the AMBER force field was parameterized with this
explicit water model.
Periodic Boundary Conditions specifically applies to a bulk solvation model where
an infinite number of copies of the cell of interest (including the protein, substrate,
and explicit waters) is made at the boundary of every cell, such that no solute ”feels”
another solute, but the continuity of a bulk solvent is maintained without external
forces, such as those used in stochastic boundary conditions.
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Classical Statistical Mechanics
It is important to understand that molecular dynamics simulations aremicroscopic
in nature (the fundamental particle is the atom), but are mathematically understood
through macroscopic concepts such as free energy. This is of historic origin because
one rarely does experiments on a single molecule in the laboratory, but instead stud-
ies a solution with enormous numbers of molecules. Because of statistical mechanics,
it is possible to gain both thermodynamic and kinetic information from the atomic
system in question, through an assembly of ensemble states. An ensemble is formally
all microscopic systems for which a single macroscopic state exists. For example,
the canocial ensemble (called NVT) is a collection of states with identical collections
of atoms (N) and constant volume and temperature (V and T). Another common
ensemble is NPT, where pressure is constant instead of volume.
Molecular Dynamics from Classical Mechanics
Molecular Dynamics arises from a simple interpreation of Newton’s second law,
F = ma where the force of an object (in this case, an atom) is dependent on the mass
and acceleration. At each step of a molecular dynamics, an atom has a position which
has been determined either from starting coordinates, or from the previous iteration
of the theory. Each atom also has a force, which determines the acceleration of that
atom (thus through integration, a velocity as a function of time can be applied to
the atom). With the new velocity applied as a function of time, the atom moves to
a new position, from which a new acceleration can be computed, etc. etc.
MD Shortcomings
MD is a very good approximation of the forces that are experienced in real experi-
mental systems. MD has correctly predicted functionally relevant binding interactions
which have later been identified in experimental X-ray crystal structures. There are
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two significant critiques of MD. First, MD does not account for electronic polariza-
tion (although it can account in a sense for molecular polarization). Second, the
potentials described for each term (bonds, angles, etc.) are most accurate near equi-
librium, which may effect a binding relationship, especially one which creates strain
in the substrate as projected the the OMPDC model. Further, bonds may not be
created or deleted (as the bonding pattern and subsequent atom type are assigned as
a function of the starting structure), which is not a factor for the complex association
that we wish to witness in these calculations.
2.4.4 Docking with GLIDE
For an excellent and in-depth review article describing flexible ligand docking the-
ory and subsequent techniques with Schro¨dinger software see Repasky, 2007. [30] In
brief, GLIDE works through the building of a protein/receptor grid, and by subse-
quently geometrically aligning a potential ligand in this grid. In this case, the ligand
is flexible to allow for many reasonable conformations of the ligand to be docked.
However, the flexibility did not seem to directly impact the results as the most stable
conformation in solution was also found to be the most stable conformation in the ac-
tive site (perhaps this is a piece of evidence that a much larger ligand actually belongs
in this active site.) In a bit more detail, the steps that are implemented in GLIDE
can be defined as docking and then scoring procedures. The steps are categorized as
follows:
1. Preparation and Docking procedures: Basic geometrical array of ”void space”
locates potential active sites (site-point search), and diameter test and subset
test build a suitable grid by which remaining scoring procedures rely on. This
set of procedures need only be completed once for each grid space.
2. Scoring procedures: Greedy score gives initial score of ligands in prepared grid,
further refinement including grid minimization and Monte Carlo simulation im-
prove the pose, and Final Docking Score is computed for ligands. At this point,
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the most favorable poses (which includes not only the conformation of the ligand
but the presence of the ligand in the active site) are scored ”highest”.
The most current form of the empirically-based GLIDE scoring function is found in
Equation 2.5. In this function, all types of interactions are accounted for and the
interaction energies summed. The interaction energies are taken from the OPLS all
atom force field. The final solvation term can take many forms and was not used
during this implementation per previous results suggesting that it is not necessary
for this type of active site method, although in retrospect and upon seeing the ac-























Madrox sampling was built from the loose conceptual basis of replica exchange
types of molecular dynamics. That is the fundamental assumption that multiple (N)
explicit states, placed purposefully (often through an elevated temperature) across a
given energy surface can be used to sample much more of the energy surface than can
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Figure 2.9. Madrox Sampling Schematic
be sampled with a collection of N states that are energetically very similar. Madrox
sampling differs from replica exchange in that the temperature is not directly affected.
Instead, a fictious energy is applied to the system locally, in discrete units of x. That
is, many copies of the ligand are applied in a literally overlapping fashion to the
active site. If the potential energy is U and all coordinates are represented by a
vector quantity R, the new potential energy after adding fictious energy (duplicated
substrate molecules) x is:
U(R, q)→ U(R, q)x (2.6)
where the fictious energy for two substrates present is actually the potential energy
of the system when a single substrate is present, squared, as x is:
x = U(R, q) (2.7)
which means that the biased potential energy grows with each number of substrate
molecules introduced into the active site (N substrates). For our example of eight
copies of substrate, the potential grows in this way:
Ueightcopies(R, q) = U(R, q)x
8 = U(R, q)9 (2.8)
The protein is constrained so that the energy can not be transferred to the protein
(i.e., so that the protein does not ”explode” in the simulation) and the simulation
is run via classical molecular dynamics. Becuase the ligands are operating within
given parameters, they were observed to not deviate from their fixed geometry, but
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instead they will leave the presence of the other ligands and occupy some new space
in the active site or in the active site tunnel, even if the energetic penalty is quite
high to doing so. The fictiously high energy need not be resolved. In fact, as long as
the constraints are taken to be sufficiently high in the protein, it matters not what
the potential becomes across the course of the Madrox sampling, nor does it matter
that the statistical distribution of states becomes completely unbalanaced, as the
system is subsequently minimized and all systems will ”settle” into an energetically
achievable position within the context of the expected potential energy surface. This
is effectively a means to distribute the a ligand into different energy wells. It was
observed that ligands that were spacially removed farthest from the original ligand
were the least likely to return upon system relaxation to the original location of the
ligand, suggesting that a high energy barrier was indeed crossed using this method.
The array of ligands themselves were obviously populating a path of least resistance,
and Madrox sampling served to discover the water channel (Figure 2.10). This method
presents an exciting and novel concept of the application of energy, indirectly, to
increase not sampling capability but instead seeding capability (otherwise, to find
many removed points along a trajectory from which sampling may then begin).
2.4.6 Car-Parrinello Molecular Dynamics (CPMD)/MD
CPMD marries the sampling abilities of Molecular Dynamics with the accuracy
and propincity for treatment of metallosystems of Density Functional Theory (DFT).
Most importantly, CPMD allows for qualitative electronic structure changes across
the course of the simulation - i.e. bond-making and breaking steps. CPMD is also
referred to as ab initio molecular dynamics, a name gained from the ”on-the-fly” gen-
eration of nuclear forces which eminate from electronic forces. This approach elimi-
nates the parameterization problem, while introducing the new problem of choosing
an approximate method for ”solving” the Schro¨dinger equation. CPMD is referred to
as plane-wave basis set pseudopotential implementation of DFT. Otherwise, CPMD
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Figure 2.10. Water Channel elucidated by Madrox Sampling and then
Confirmed by Molecular Dynamics
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implements Density Functional Theory (DFT) to treat the electron-electron interac-
tions, specifically expanding wave-functions using plane waves (which are independent
of atomic positions), and a pseudopotential (which is a potential with the core elec-
trons ”frozen”). In CPMD/MD, the theories of CPMD can be implemented in a
region, such as the active site of the FrsA protein, where chemistry is expected to
occur. The rest of the protein and solvent is then treated with classical molecular dy-
namics. CPMD/MD implementations are unmatched in prediction of macrocanocial
values such as energies, in particular interest to this case where the energy barrier
of the FrsA reaction with pyruvate, as well as the specific chemical steps, are of
particular interest.
2.4.7 Thermodynamic Integration
Thermodynamic Integration (TI) is used in conjunction with CPMD/MD in order
to calculate a reaction trajectory along a fictious reaction coordinate. In this case,
the coordinate was the bond length of the carbon-carbon bond. TI works in this case
to compare the change in free energy between two states (carbon-carbon bond intact
and cleaved), because we can assume that each state will have a different free energy
as a function of the spatial coordinates. This can not be calculated directly as a
function of the spatial coordinates but instead of phase space itself, a function of the
enthalpic average of states across the ”path”. Mathematically, consider a potential
energy function Uλ with a coupling parameter λ. λ is defined with limits of 0 and 1,
(λ10), where the system is in state y (Uy) when λ = 1 and where the system is in state
x (Ux) when λ = 0:
Uλ = Ux + λ(Uy − Ux) (2.9)
The partition function of this sytem is:





and the resulting free energy is:
F (N, V, T, λ) = −kBT lnQ(N, V, T, λ) (2.11)
and the derivative of the free energy with respect to λ is:














This was calculated in this case by calculating this energy function at a series of λ
values, and finally computing the integral over the averaged derivatives. There are
some assumptions and issues when employing thermodynamic integration. One is that
the parameter in question (λ) is changed infinitely slowly to accomodate equilibration
(thus producing perfect reversiblility of the trajectory). In practice, the λ is nudged
in 0.25 pm increments, and then ”adequate” time is provided for equilibriation at this
new point.
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ABSTRACT: The fermentation−respiration switch
(FrsA) protein in Vibrio vulnif icus was recently reported
to catalyze the cofactor-independent decarboxylation of
pyruvate. We now report quantum mechanical/molecular
mechenical calculations that examine the energetics of C−
C bond cleavage for a pyruvate molecule bound within the
putative active site of FrsA. These calculations suggest that
the barrier to C−C bond cleavage in the bound substrate is
28 kcal/mol, which is similar to that estimated for the
uncatalyzed decarboxylation of pyruvate in water at 25 °C.
In agreement with the theoretical predictions, no pyruvate
decarboxylase activity was detected for recombinant FrsA
protein that could be crystallized and structurally
characterized. These results suggest that the functional
annotation of FrsA as a cofactor-independent pyruvate
decarboxylase is incorrect.
A recent report identified the fermentation−respirationswitch (FrsA) protein in Vibrio vulnif icus to be a cofactor-
independent pyruvate decarboxylase (Scheme 1).1 Indeed, FrsA
was reported to exhibit a kcat of approximately 1400 s
−1 at 37 °C,
which is considerably greater than the value observed for the
turnover number of the thiamin-dependent pyruvate decarbox-
ylase from Saccharomyces cerevisiae.2 This remarkable finding, if
correct, would imply a significant shift from the current paradigm
that Nature evolved the thiamin cofactor to generate resonance-
stabilized acyl carbanion equivalents in all kingdoms of life when
catalyzing the oxidative and nonoxidative decarboxylation of α-
ketoacids. The X-ray crystal structure of unliganded FrsA,1 which
revealed a putative active site containing residues similar to those
present in orotidine 5′-monophosphate decarboxylase
(OMPDC),3−5 provided a chemical rationale for the unexpected
functional assignment of FrsA. Thus, it was argued that the
catalytic power of the enzyme derived from electrostatic
repulsion between pyruvate and the negatively charged side
chain of Asp-203 in FrsA.1 We were intrigued by these
conclusions for two reasons. First, the three-dimensional fold
of FrsA places it within the α,β-hydrolase superfamily of
enzymes,6 which are known to catalyze a diverse array of
reactions,7 including the decarboxylation of β-ketoacids to yield
methylketones.8 OMPDC has a different fold, however, and this
lack of structural similarity precludes any direct evolutionary
relationship between the two enzymes.5 Second, considerable
evidence exists to suggest that stabilization of the carbanion
intermediate formed in the OMPDC-catalyzed reaction is
enabled by binding energy obtained from the extensive set of
interactions of the protein and the sugar−phosphate moiety of
the OMP substrate.9,10 On the other hand, the energy released by
the interaction of the methyl substituent with FrsA and the small
number of hydrogen bonds to the carbonyl group seem
insufficient for stabilization of any acyl anion intermediate
formed during FrsA-catalyzed decarboxylation. We therefore
used advanced computational methods to evaluate the energetics
of the proposed mechanism for FrsA-catalyzed conversion of
pyruvate to acetaldehyde and also prepared and assayed
recombinant V. vulnif icus FrsA to determine whether the
reported activity could be reproduced.
The model of the FrsA−pyruvate complex used in our
computational studies was based upon the “open” monomer in
the crystal structure of the free enzyme (Protein Data Bank entry
3MVE). After hydrogen atoms had been added, the protein was
placed in a box of TIP3P water molecules11 containing two
chloride ions to yield a neutral system. The resulting structure
was energy minimized and equilibrated by molecular dynamics
(MD) simulation. Parameters for pyruvate were obtained from
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Scheme 1. Cofactor-Independent Decarboxylation of
Pyruvate Showing the Putative Acyl Anion Intermediate
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the generalized AMBER force field,12−14 and the substrate was
docked into the putative enzyme active site using GLIDE.15
Energy minimization and MD equilibration of several model
complexes with pyruvate in different orientations within the
putative active site all gave the same final position for the
substrate (Figure 1). The final equilibrated structure of the
pyruvate−FrsA complex resembled the one proposed previ-
ously,1 with pyruvate forming hydrogen bonds to the side chains
of the backboneNHgroup of Leu-202, and the side chains of Arg-
272 and Tyr-316. In addition, three active site water molecules
associated strongly with bound pyruvate throughout these MD
simulations. This solvated model of the pyruvate−FrsA complex
proved to be stable in an unconstrained NPT MD simulation
over a period of 20 ns and was used in a series of quantum
mechanical/molecular mechanical (QM/MM) simulations of
the C−C bond cleavage reaction employing an extension of the
Car−Parrinello MD (CPMD) methodology.16 The QM region
consisted of pyruvate, the Tyr-316 side chain up to the Cβ atom,
and three active site waters. These atoms were described by the
BLYP functional17,18 and norm-conserving Martins−Trouiller
pseudopotentials19 with dispersion-corrected atom-centered
dispersion potentials.20−22 The remaining atoms, comprising
the rest of the protein and explicit water molecules, were
described by the classical AMBER99 force field.13,14 The side
chains of the hypothetical “catalytic residues”, Asp-203 and Arg-
272, were not included in the QM region because their putative
electrostatic contributions to catalysis could be adequately
represented using anMMdescription. In theCPMDcalculations,
the C1−C2 bond distance in pyruvate was chosen as the reaction
coordinate; hence, constraints were employed at distances of
1.55−4.24 Å (in increments of 25 pm). The QM/MM system
was equilibrated for 2 ps at constant pressure and temperature
before constrained MD simulations were performed for
thermodynamic integration23,24 in the NPT ensemble. Each
system was sampled for 1 ps, and the free energy profile was
computed by integrating the constraint forces over the respective
distances (Figure 2). These simulations gave an estimated free
energy barrier of 28.1 ± 0.2 kcal/mol for the conversion of FrsA-
bound pyruvate into acetaldehyde and CO2, corresponding to a
first-order rate constant of 1.1 × 10−9 s−1 at 25 °C, assuming
transition state theory and the absence of recrossing.25 This value
is very similar to the experimental estimate of the first-order rate
constant for the uncatalyzed decarboxylation of pyruvate, which
has an upper limit of approximately 10−9 s−1 at this temperature
and pH 7.26 The calculated value should be considered as a lower
bound given that BLYP is known to underestimate activation
barriers, especially those for proton transfer steps.29 For example,
“benchmark” studies give an estimate of 23.0 ± 3.1 kcal/mol for
the uncatalyzed reaction inwater, which is consistent with that for
the putative FrsA-catalyzed reaction when error estimation is
taken into account. Certainly, both computed barriers are
inconsistent with the reported1 turnover number of 1400 s−1 for
FrsA-catalyzed decarboxylation. Furthermore, the notion that the
FrsA protein environment does not catalyze C−C bond cleavage
is supported by the fact that the QM/MM simulations suggest
that a nearby tyrosine residue (Tyr-316) protonates pyruvate
during the reaction mechanism (Figure 3 and the Supporting
Information). This proton is subsequently transferred to a nearby
water molecule at the transition state (C−C bond length of 3.1
Å). The resulting hydronium ion stabilizes the developing
anionic charge on the central carbon atom when the C−C bond
in the substrate is elongated to 3.3 Å and protonates the acyl
anion, thereby giving acetaldehyde (Figure 3). Both the initial
deprotonation of tyrosine by substrate and the subsequent
transfer of a proton to water are counterintuitive on the basis of
standard pKa values, and calculations
28 do not support any large
pKa shifts for either Tyr-316 or bound pyruvic acid (Supporting
Information). These computational findings again argue that
FrsA is unlikely to be a cofactor-independent decarboxylase.
Figure 1. Equilibrated model of pyruvate (orange) docked into the
putative active site of FrsA. Pyruvate is hydrogen bonding to the
backbone NH group of Leu-202 and the side chains of Tyr-316 and Arg-
273. Color scheme: cyan for C, white for H, blue for N, and red for O.
Active site water oxygen atoms are rendered as red spheres.
Figure 2. Free energy profile for cleavage of the C1−C2 bond in FrsA-
bound pyruvate, as computed by thermodynamic integration. Error bars
show the statistical sum of errors associated with the calculated free
energy. The inset shows the active site configuration at the transition
state (C−C bond length of 3.3 Å) and the transfer of a proton from a
hydronium ion to the acyl anion.
Figure 3.Molecular events observed during the cleavage of the C1−C2
bond in FrsA-bound pyruvate. (a) Protonation of the substrate
carboxylate by the side chain of Tyr-316. (b) Deprotonation of the
carboxylic acid via a nearby water molecule. (c) Formation of a
hydronium ion during decarboxylation, which then acts to quench the
developing anionic charge on C2, thereby yielding acetaldehyde (d).
Atoms in the QM and MM regions are rendered as “ball-and-stick” and
licorice representations, respectively. Proton transfers are shown using
“dynamic bonds”. Color scheme for the QM atoms: gray for C, white for
H, and red for O.
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To evaluate the conclusions about the QM/MM and pKa shift
calculations, the gene encoding V. vulnif icus FrsA was expressed
in Escherichia coli and purified via two different procedures. In
agreement with the computational results, neither preparation
exhibited detectable pyruvate decarboxylase activity (acetalde-
hyde production or CO2 evolution) in a coupled-enzyme
spectrophotometric assay (alcohol dehydrogenase), by 1H
NMR spectroscopy, or by membrane-inlet mass spectrometry
(Supporting Information).29 The purified protein was, however,
crystallized and its structure determined at 1.95 Å resolution; our
structure was essentially identical to that reported earlier except
an unknown ligand, modeled as hexanoate, was located in the
putative active site (Figure 4). Given that α,β-hydrolase
superfamily members are functionally diverse,8 it is difficult to
predict in vitro activity solely from sequence homology.
However, these computational, structural, and experimental




Procedures for the CMPD simulations and pKa estimates, and
details of the purification, assays and new X-ray crystal structure
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3. Control Strategies of the Enzyme Methylmalonyl-CoA Mutase
Enzymes catalyze reactions at amazing rates, all while avoiding unwanted side re-
actions. Many proteins accomplish this feat through metal-based cofactors [31], or
through specific protein folds incorporating an array of amino acids, such is the case
in the five-cysteine-core of Ribonucleotide Reductase. [32] It is clear that nature nec-
essarily invented very complex systems to deal with radical reactions, often designing
large and complex cofactors, sometimes including transition metals, to accomplish
this feat. In this chapter, we study aspects of the mechanism of the B12-dependent
enzyme, Methylmalonyl-CoA mutase. The experimental and computational systems
that are developed in this mechanistic endeavor then form a basis for Methylmalonyl-
Coa engineering efforts which are successful in designing a purely enzymatic pathway
to produce 3-hydroxypropionate (3-HP).
3.1 Introduction
3.1.1 B12 in Human Biology
B12 is a necessary nutrient that can not be synthesized by the human body but
must be digested from foodstuffs or possibly be produced by intestinal bacteria. Ad-
ditionally, a protein intrinsic factor is necessary for the absorption of vitamin B12
from the digestive tract into the blood stream. [33] B12 is necessary for many fun-
damental reactions in the human body such as DNA replication, protein synthesis
and red blood cell production. The condition of having low B12 levels in the body
is diagnosed as pernicious anemia, which initially presents with exhaustion, coldness
in the hands and feet, pale skin and shortness of breath. Advanced symptoms can
38
include arrhythmias. The strain placed on the heart by continual arrythmia can even
lead to eventual heart failure. [34]
3.1.2 B12 Cofactor
The term vitamin B12 actually refers to the core struture of the B12 coenzyme,
which consists of the central corrin ring, an R-group found at the top axial position
of the ring, and a nucleotide-capped loop protruding from the ring, which in solution
is bound in the bottom axial position of the ring. This core structure has two axial
positions which are altered to form the Coenzyme B12. The coenzyme has, in place
of the top axial ligand, an adenosylcobalamin moiety. In the case of the cofactor, in
the place of the bottom axial position (in substitution for the dimethylbenzimidazole
(DMB) tail) binds a histidine residue from the protein itself. This histidine binding
tethers the cofactor to the protein ”covalently” and induces a conformational change
in the DMB tail, which then occupies a hydrophobic cleft in the protein cofactor
binding site. [35] More details regarding the structure and naming conventions of the
B12 cofactor can be seen in Figure 3.1.
3.1.3 B12 dependent enzymes
There are three classes of B12 dependent enzymes: the methyltransferases, iso-
merases and reductive halogenases. Each class is dependent on a different form of the
B12 cofactor, with the isomerases being deoxyadenosyl dependent. This cofactor is
named coenzmye B12, or AdoCbl. The largest family of B12-dependent enzymes are
the isomerases (including Methylmalonyl-CoA mutase, the subject of this chapter).
Because the actual form of the B12 cofactor differs in the other classes, they operate
via different mechanisms and are not discussed further. [33]
The B12-dependent isomerases include not only Methylmalonyl-CoA mutase, but
also glutamate mutase, D-ornithine aminomutase, isobutyrl-CoA mutase, methyleneg-
lutarate mutase, ethanolamine ammonia lyase, diol dehydrase, β-lysine mutase, and
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Figure 3.1. Adenosylcobalamin (AdoCbl) Cofactor (Reproduced with
permission [35])
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finally, ribonucleotide reductase, an enzyme fundamental to DNA replication, repair
and other processes, which specifically catalyzes the conversion of RNA to DNA. The
reaction catalyzed generally by this class of enzymes is a 1,2-rearrangement reaction
between substituents on adjacent carbons. [34]
3.1.4 Methylmalonyl-CoA Mutase
The enzyme Methyl Malonyl-CoA Mutase (MCM) catalyzes the conversion of
methylmalonyl-CoA to succinyl-CoA via a radical intermediate which abstracts one
specific hydrogen from a methyl group. Methylmalonyl-CoA Mutase from the or-
ganism Propionibacterium shermanii is a heterodimer composed of a major alpha
subunit, which binds substrates and cofactors, as well as a minor beta subunit, which
may not be necessary for catalysis, although it is generally considered necessary for
maximum catalytic efficiency. In the human form of the enzyme the alpha sub-
unit is quite similar to the P. Shermanii α subunit, forms an α:α homodimer. This
propincity for formation of the α:α homodimer creates an issue when producing this
enzyme recombinantly.
This metalloenzyme utilizes the adenosyl-cobalamin(AdoCbl) cofactor, a complex
organometallic cofactor containing a tetrapyrrolic cobalt as well as the only true
metallo-organic bond in nature, the cobalt-carbon bond. Further, this cofactor binds
the protein directly, by substitution of one of the four substituents that extends from
the fourth pyrole ring with a protein based histidine. This feature provides for binding
free energy to secure this large cofactor adjacent to the protein active site. The cobalt-
carbon cleaves homolytically to produce Co3+ and an adenosyl radical, which then
abstracts the methyl group hydrogen. I then propose that the CH2 based radical forms
a new cyclopropanic carbon-carbon bond with the pi-based radical from the C-O bond.
This strained structure immediatly devolves to a single chain through the cleavage
of the C-C bond which joined the thioester group to the carbonyl group, forming a
new carbon-based radical on what is now the alpha carbon to the carboxyl group.
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Figure 3.2. Methylmalonyl-CoA mutase quaternary structure
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Figure 3.3. AdoCbl binding in the MCM active site
This radical abstracts a hydrogen from the Adenosyl moiety which than recapitulates
a organometallic bond between the corrin based cobalt atom. The cofactor has now
been re-established and the oxidation state of Cobalt has returned to Co2+. First,
The adenosyl radical harbored by MCM must be highly reactive in order to abstract
a specific hydrogen of the methyl group on the substrate methylmalonyl-CoA, but
must also be sequestered in order to prevent side activity or premature activity with
the departed Co3+ moiety. Specific to this goal is a Adenosyl moiety C3′-endo to
C2′-endo conformational switch, which we call the mechanochemical switch. When
this switch is off (C3′-endo) - the proper hydrogen (primary) is abstracted with a
lower energy compared to other available hydrogen atoms, such as the hydrogen
of the tertiary carbon adjacent to the CH3 moiety. Interestingly, the reaction of
the hydrogen at this tertiary carbon reacts favorably if the ”switch” is flipped on
prematurely. This provides additional evidence that the position of the switch is, at
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Figure 3.4. Proposed mechanism for the MCM catalyzed conversion
of methylmalonyl-CoA to succinyl-CoA
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Figure 3.5. Mechanochemical switch. Residue E370D (bottom left)
stabilizes ”state 1”, also called switch ”on”.(ref)
least energetically, favorable as a reaction dependent control mechanism. This switch
appears to be stabilized in the ”on” position by hydrogen bonding with glutamate
residue 370 (E370). The goal of these studies is to test the computationally proposed
mechano-switch hypothesis using site-directed mutagenesis studies. In this case, a
mutant (E370D) was designed that gives preference to the first (inactive) C3′-endo
”switch state”. If this mutant is less active than the WT, it provides evidence for
the existence of the switch, as the role of the residue in question is not obviously
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Figure 3.6. Proposed qualitative/comparative free energy diagram for
the reaction catalyzed by MCM indicating all reaction intermediate
structures
relevant to catalysis in the absence of the switch. Further studies on another mutant,
T166D, probe the accuracy of the computational model from which we designed the
”switch state” theory. In this project, computational enzyme redesign was based on
this model, with implications in protein/enzyme engineering/design.
3.2 Results and Discussion
It is important to note before continuing with reporting of results that significant
methodological preparation in both enzyme production and assay was required. These
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details are necessarily included in the Methodology section at the conclusion of the
is chapter.
3.2.1 E370D - Mutant Reducing Stability of Ribose Switch
According to the computationally projected mechanoswitch hypothesis, ”State
1 has a hydrogen bonding interaction with residue E370, while as ”State 0” (the
unactivated state) has no such interaction. In the E370D mutant, this interaction is
altered such that the hydrogen bond (between the same donor partners as is in the
WT) is forcibly longer as a because Asp is a smaller functional than Glu group. The
”State 1” conformation is energetically important for proper catalysis, as is indicated
by the fact that the wrong state at any given stage of catalysis results in energetically
favorable side reactions. The mutant is predicted to be slower than the WT enzyme,
as ”State 1” is now less stable compared to WT. Indeed, the results of this experiment
are found in Figure 3.7. The degradation of Methylmalonyl-Coa was measured as the
assay requirement, because Succinyl-coa (the product) is not incredibly stable under
the assay conditions which require hours of monitoring. The assay shown here is from
the purified protein, although it can be reproduced reliably with cell lysate if needed.
The E370D protein appeared to be about 1
3.2.2 T166D - Mutant that Alters the MCM Substrate
It was recently proposed that the enzyme MCM could convert the non-natural
substrate Lactoyl-CoA into 3-HP-CoA with a single point mutation, T166D. If this
result is reproducible experimentally, this is incredibly exciting because of not only the
successful computational enzyme design, but also practically, as this result provides
the missing link to a complete enzymatic pathway for the creation of 3-HP (an expen-
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Figure 3.7. Effect of MCM E370D mutation on concentration of
Methylmalonyl-CoA as a function of time
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Figure 3.8. Potential pathways to 3-HP from pyruvate. Known enzy-
matic transformations are shown in black and unknown transforma-
tions (which require enzyme engineering or organic synthetic chem-
istry steps) are shown in Red. Reproduced with permission [23].
sive commodity chemical) from pyruvate. One can see in Figure 3.8, that pyruvate
can be made into 3-HP enzymatically through the following transformations:
pyruvate→ lactate (3.1)
lactate→ lactoyl − CoA (3.2)
lactoyl − CoA→ 3−HP − CoA (3.3)
3−HP − CoA→ 3−HP (3.4)
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Figure 3.9. Structures of MCM native and novel substrates and products.
Figure 3.10. LC-MS, showing the selected mass count for lactoyl-
CoA/3-HP-CoA. T166D shows no background mass counts at this
m/z ratio. Upon addition of lactoyl-CoA, T166D produces a new




In this section we predicted the presence of a mechanochemical switch based ob-
served movement of a ”switch” in the B12-dependent Methylmalonyl-CoA Mutase.
The presence of the ”switch” is supported by the role of a mutant with no clear
mechanistic deleterious purpose, outside of de-stabilizing the switch. Then, we con-
firmed the quality of this computational model by reproducing a computationally
designed protein, T166D, that was predicted and indeed appears to make 3-HP-CoA
from Lactoyl-CoA. This fills in the remaining gap in enzymatic production of 3-HP
from pyruvate, a massive stride towards the production of this extremely expensive
industrial chemical.
3.4 Methodology
3.4.1 Protein Production Development
Current protocols for producing MCM exist in the literature, but many were
created before the advent of modern protein purification technoologies, and are of
extremely low efficiency. Therefore, it was necessary, in order to purify the number
of mutants required in the course of this project, to invent a new protein production
scheme. This included a revisitation of current codon optimization strategies.
Aside from a need for codon optimization, expression and re-constitution of het-
erodimeric enzymes can be challenging, especially in the case of MCM which contains
additional metal or organic cofactors. As an additional complication, the MCM α
subunit has an affinity for itself, but the α/β heterodimer is the desired purification
product. This protocol was developed as an efficient strategy to express and purify
this heterodimeric enzyme efficiently, with no byproducts of unintended complexes.
This protocol could be adapted beyond the assembly of this heterodimeric protein
and applied to more complex assemblies. Before continuing with the details of this
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protein production pathway, I will mention briefly the codon-optimization protocol
that we designed specifically for this project, which has potential for much wider use.
Codon/tRNA ratio tuning (CRT)
The genes were synthesized first, to incorporate several codon changes. Codon
optimization has been touted as a way to improve in vitro expression of proteins in
a non-native expression system. A simple approaches towards codon optimization is
to optimize a single codon to the highest frequency version of that particular codon
for that amino acid. For example, all Leucine residues within a given protein may
be represented with the codon CUG. Commercially available codon optimization
alogorithms, which are often proprietary in nature, may be as advanced to account
for average codon usage in different regions of an organisms DNA. However, even these
algorithms fail to improve gene expression in a predictable way. Anecdotal cases exist
of genes that are riddled with rare codons but express beautifully. This fact suggests
that rare codons are not necessarily deleterious for gene expression. Further, rare
codons may play a role as molecular stop-gates or speed-bumps for translation [36],
which have a specific and intentional role in modulating the speed of translation and
thus result in a more aptly folded (and therefore stable) final protein product.
The codon changes in this project were not incorporated with any current codon
optimization protocols but instead were constructed with consideration of not only
the codon frequency within the E. Coli (expression) organism, but also the frequency
of the codon in the host organism, [37] as well as the tRNA availability in both host
and expression organisms. Upon doing this, codons were used at specific residues in
order to match the tRNA availability of the host organism to that of the original or-
ganism from which the gene is originated. We call this method of codon improvement
”Codon/tRNA ratio tuning” (CRT). By applying CRT, we were able to produce a
stably expressed (but not necessarily massively expressed product). This is because
CRT does alter codons for massive overproduction of the protein, but instead main-
52
tains the natural ”speed bumps” that are placed by the orginating organism due to
the lack of immediate tRNA availability. Specifically targeted were the codons for
Proline, which show great discrepancy in tRNA availability between P. Shermanii
and E. Coli.
Cloning of the MCM Construct
P. shermanii mutB and mutA genes which code for the α subunit and β subunit,
respectively, were codon optimized for expression in E. coli and the optimized genes
were synthesized by Life Technologies (Grand Island, NY). The genes were digested
with restriction enzymes and ligated stepwise into pETDuet-1 (Novagen/Millipore,
Darmstadt, Germany) with mutA and mutB ligated into MCS1, between EcoRI
and HindIII, and MCS2, between NdeI and XhoI, (respectively,) and with a N-
terminal His-tag on the mutA product. This tag location was chosen because this N-
terminus of the β subunit appears to have minimal contribution to any potential α/β-
heterodimer interactions based on crystallographic B-factor of the region (compared
to other accessible taggable termini.) It was favourable to tag the β subunit instead
of the α subunit, because α/α homodimers are known, (these are analogous to the
known human MCM dimerization). Restriction enzyme digests and then sequencing
of the plasmid ensure inclusion of both gene products in the plasmid.
Transformation and Expression of MCM
Purified and sequenced construct was transformed into BL21DE3 chemically com-
petent cells. 500 mL x 12 Luria Broth in baffled flasks with Ampicillin (0.1 mg/mL
final concentration) were inoculated with 6mL of MCM:BL21 culture grown overnight
at 37◦C in LBA. Cells were grown at 37◦C until OD595 is reached The cell growth into
lag phase (versus log phase) seemed to increase protein yields considerably, although
mostly in the insoluble pellet, which then must be retrieved. Cultures were heat
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shocked for 10 minutes at 42◦C and then grown at 37◦C with 220 rotations/minute
shaking for 8 hours.
Purification of MCM
Many important biological complexes are formed from the association of two non-
identical proteins: the oncogenetically indicated bHLH-PAS proteins [38], therapeu-
tically relevant (and non-biologically occurring) cytokine heterodimers [39], and the
oncogenetically linked HIFα/HIFβ transcription factor [40] are just a few examples.
In general, a large number of protein-protein interactions are responsible for critical
cell signaling and therefore the diseases that emanate from their disruption. Form-
ing pure solutions of these heterodimeric complexes in vitro is necessary to conduct
solution (activity) and crystallographic (structural) studies, and then to design and
test drugs in the laboratory and on the computer.
The protein products of linked genes are often expressed at nearly identical rates,
partly as a function of chromatin structure [41]. This strategy models the 1:1 nature of
in vivo protein expression by placing the genes one-after-another on the same plasmid.
The commercially available PETDuet (Novagen) vector mimics this arrangement.
In this case, two polypeptides (α and β), assemble to form a biologically ac-
tive α/β construct in the heterodimeric Methylmalonyl-CoA Mutase (MCM) from P.
Shermanii. Traditionally, each subunit (α or β) has been expressed independently,
and then later incubated to form an active dimer. However coexpression of genes
that are found in nature has been shown to significantly improve protein yield and
folding. [42] Furthermore, in enzymes such as MCM, the biologically irrelevant α/α
subunit is formed under such conditions, in addition to the desired α/β structure.
Once these stable non-biological dimers have formed, a mixture of at least two dimers
(α and α/β) exists in solution, and any solution or crystallographic structural studies
suffer from this heterogeneity. Previous efforts to express heterodimeric proteins in
one step have involved mutation of the interacting protein(s) themselves, perhaps in
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the most robust case by design of a flexible linker region. [43] Although this fusion
protein strategy presents an excellent initial model, and in some cases, activity is
reported to be unchanged, it raises some doubts about the true effect of the covalent
modification, particularly on the dynamics of the new covalently bound heterodimeric
complex. Because many of these proteins may be involved in a complex cascade of
protein-protein interactions, covalent modification presents the potential for deleteri-
ous impact on downstream interactions.
Specifics of the purification scheme are as such (and align with roman numer-
als found in Figure 3.11). N-terminal 6XHis-tag β-subunit (mutA gene) is cloned
into MCS1 and un-tagged α-subunit (mutB gene) is cloned into MCS2 in the com-
merically available pETDuet-1 plasmid. The plasmid is transformed into JM109 E.
Coli and plasmid is purified for sequencing, and purified plasmid is transformed into
BL21DE3 E.Coli for expression. Cells are grown using a standard protocol, II) lysed,
centrifuged, resuspended, centrifuged again, and all lysate collected. The pool of pro-
teins at this point III) contains α subunits, α/α dimers, and α/β dimers. This pool
is loaded onto a Ni(II) column with affinity for the 6X-Histag on the protein, and
the elution V) contains only α and α/α subunits, while the column is now binding
VI) β subunits (and possibly some α/β dimers) through the His-tag. The pool from
step V (containing α only subunits or dimer) is then added back to the column from
step VI to ensure that all bound β subunits can partner with an α subunit to make a
heterodimer, the wash from the column (VIII) is discarded, and the elution from the
column (IX) is a homogeneous mixture of α/β dimer.
Pellet was dissolved in lysis buffer (see Table 3.1 for all buffer compositions). Cells
were sonicated for 20s x 6 with 30 s rest to rupture cell walls. Cells were centrifuged
for 1 hr at 2000xg at 4◦C. Cleared lysate was collected. Remaining pellet was again
dissolved in lysis buffer and sonicated, this time for 59s x 6 with 60 s rest, centrifuged,
and the cleared lysate collected. Appreciable amounts of soluble protein were detected
in both cell lysate solutions (from first and second centrifugation,) and thus the lysate
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Figure 3.11. Single column MCM purification schematic. All roman
numerals correspond to steps in the text.
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was pooled and stored at 4◦C overnight or for up to 72 hours before purification. The
cells were purified via the N-terminal 6x His-tag on mutA on Ni2+ binding resin.
Table 3.1.
MCM Purification Buffer Compositions
Buffer Potassium Phosphate Conc. NaCl Conc. Imid. Conc.
Lysis** 50 mM, pH 7.5 150 mM 0 mM
Wash 50 mM, pH 8.5 500 mM 5 mM
Elution 50 mM, pH 8.5 500 mM 20 mM
Wash/Storage 50 mM, pH 7.5 150 mM 0 mM
** and 0.1 M EDTA, 5 mM Benzamidine HCl and 0.1 mM PMSF.
Reconstitution of MCM with cofactor
To the protein was added Adenosylcobalamin (>97%, Sigma-Aldrich, St. Louis,
MO) and the mixture was exchanged into 50 mM potassium phosphate, pH 7.5, 150
mM potassium chloride via dialysis for 24 hours and at 4◦C in the dark. Excess
cofactor was removed with a P-30 spin column (Bio-Rad, Hercules, CA.) Further
purification was not necessary for our purposes (based on the visible band sizes and
apparent 1:1 concentration on a Coomassie Blue stained SDS-Page gel).
3.4.2 Assay of MCM activity
Although a fully-automated MCM cell lysate assay has been developed [44], the
chromatography was not sufficient to separate other substrate and product CoA es-
ters, such as those required by the T166D mutant, from CoA, much less from each
other. Therefore, an assay was developed to measure the activity of the enzyme by
monitoring a range of CoA ester concentrations.
57
MCM was assayed by Accurate-Mass Q-TOF LC/MS (Agilent, Santa Clara, CA)
with an Agilent 1200 Poroshell 120 EC-C18 3 x 150 mm 2.7 m column. Flow rate was
0.6 mL/min through the column, and the column and solvents were maintained at
45◦C. Solvents were 98% water with 5 mM ammonium acetate and 2% acetonitrile and
methanol with 5 mM sodium acetate. Purified protein (5 mg), previously reconsti-
tuted with cofactor was added to substrate (methylmalonyl-CoA lithium salt, 0.1 mg,
Sigma-Aldrich, St. Louis, MO) and run for several time points as well as overnight at
37◦C in 250 mL reaction volumes. 10 mL of each reaction was injected for analysis and
the mass spec peaks for methylmalonyl-CoA were integrated and analyzed against a
standard curve constructed of five different substrate concentrations (Agilent Mass
Hunter Acquisition and Q-TOF Quantitative Analysis software). It was observed
that the methylmalonyl- CoA substrate (Sigma) gave 2 peaks with m
z
ratio of 867,
the second peak of which is assumed to be the isomer of methylmalonyl-coa where the
monophosphate is attached to the 2 carbon of the ribose ring (instead of the 3). This
isomer-CoA is known and is separable via LC-MS. These peaks maintained stability
throughout the course of our experiments and beyond, both in retention time and
in the observed m
z
. No other m
z
ratios appeared in these samples, and this substrate
appeared to be extremely stable in our assay conditions. Succinyl-CoA was observed
to be readily degraded to CoA and a smaller molecule in our assay conditions, which
is not surprising, based on the easily hydrolyzed nature of this side chain, and so we
assayed only product degradation. As methylmalonyl-coa (substrate) was consumed
in the course of the reaction, we saw CoA evolved, not as a direct product but instead
as the result of succinyl-coa hydrolysis. We can differentiate between the substrate or
product and free CoA by m
z
, and also by the five different retention times of substrate,
iso-substrate, product, CoA and iso-CoA. We did establish that with our method the
methylmalonyl-CoA and free CoA peaks are all separable with our LC conditions
and the given column, solvents and flow rate (Figure 3.12). All chemicals, unless
otherwise noted, were obtained from Thermo-Fisher Scientific or Sigma-Aldrich.
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Figure 3.12. The Substrate (Methylmalonyl-CoA and the Product
(Succinyl-CoA) are separated under the specific LC-MS conditions
discussed. These compounds are also separated from CoA.
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ABSTRACT: B12-dependent enzymes employ radical species
with exceptional prowess to catalyze some of the most
chemically challenging, thermodynamically unfavorable reac-
tions. However, dealing with highly reactive intermediates is an
extremely demanding task, requiring sophisticated control
strategies to prevent unwanted side reactions. Using hybrid
quantum mechanical/molecular mechanical simulations, we
follow the full catalytic cycle of an AdoB12-dependent enzyme
and present the details of a mechanism that utilizes a highly
effective mechanochemical switch. When the switch is “off”,
the 5′-deoxyadenosyl radical moiety is stabilized by releasing the internal strain of an enzyme-imposed conformation. Turning
the switch “on,” the enzyme environment becomes the driving force to impose a distinct conformation of the 5′-deoxyadenosyl
radical to avoid deleterious radical transfer. This mechanochemical switch illustrates the elaborate way in which enzymes attain
selectivity of extremely chemically challenging reactions.
Enzyme regulation is not only about facilitating targetreactions but also about preventing those that are
undesired. The idea that enzymes lower the activation energy
of a chemical transformation is central to the understanding of
how enzymes catalyze reactions at astounding rates, relative to
the uncatalyzed process in solution. However, reactions that
involve highly reactive and unstable intermediates, such as a
radical species, present an entirely new set of catalytic
challenges. Under these circumstances, the challenge of
attaining reaction selectivity requires stabilizing and prolonging
the lifetime of the reactive intermediates to ensure proper
product formation. For this task, it has been suggested that
certain enzymes resort to using a tactic that prevents reactive
intermediates from undergoing spontaneous and erroneous
side reactions in an effort to stabilize themselves.1 Potentially
threatening side reactions can encumber specificity by
competing with the native radical transfer mechanism by
having lower kinetic barriers and forming products that are
more stable.
Naturally, the long list of complications that could potentially
annihilate radical chemistry raises the question: what is the
payoff in dealing with such highly reactive species? In the case
of vitamin B12, nature has found an elegant way to employ a
radical species with exceptional prowess in order to catalyze
some of the most chemically challenging, thermodynamically
unfavorable reactions. For 5′-deoxyadenosyl-cobalamin
(AdoCbl) dependent isomerases, homolysis of the carbon−
cobalt bond (Co−C), the so-called “radical reservoir”,2
generates a highly reactive, primary carbon radical species
(designated Ado· in Figure 1a), which has the capability of
abstracting a primary hydrogen atom from an unactivated
carbon atom of the substrate. Thus, accomplishing the feat of
Co−C bond homolysis provides a very useful tool for enzymes
to meet the demands of particularly challenging chemical tasks,
such as, in the case of methyl malonyl-CoA mutase (MCM)
and glutamate mutase (GM), carbon skeleton rearrangements.
However, enzymes pay a high price to make use of the
potency of such a radical reservoir. The cost of using this tool is
manifested in two ways: (i) the energy required to form the
radical intermediate and (ii) the energy required to control it.
For the first point, breaking the Co−C bond requires
overcoming an energetic barrier of 31.0 ± 1.5 kcal mol−1 in
solution3 or 15−17 kcal mol−1 in an enzyme environment.4 It
has been suggested that AdoCbl bond labilization may, in part,
be achieved by steric crowding, through local interactions with
the 5′-deoxyadenosyl radical moiety, angular distortions in the
corrinoid ring, or encumbrance by an active site residue.5
Additionally, substrate-induced, large-scale domain motions
appear to be coupled to the activation of the AdoCbl bond in
certain AdoCbl-dependent enzymes.6 However, once homolysis
has been accomplished, the enzyme’s work is not yet finished;
the radical site must be transferred to the substrate to initiate
the rearrangement reaction. To this end, migration of Ado·
takes place over several angstroms,7,8 in certain cases as far as
10 Å from its original position,9 proximal to co(II)balamin.
This leads to the second point: stabilizing Ado· during this
translocation is of the utmost importance to ensure that the
radical reacts with the proper atom on the substrate for the
desired transformation.
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To avoid factors that jeopardize selectivity, a radical
intermediate must be protected predominantly from potential
threats of the solvent, the protein environment, and itself.
Protection from these agents may take place in the form of
sequestration from groups that might react with it and/or steric
tuning to avoid conformations from which undesired reactions
are likely to occur. It has been suggested that protection of the
radical species from solvent is achieved through a common
architecture, found in numerous AdoCbl-dependent enzymes,
that is, the (β/α)8-TIM-barrel structural motif. This fold is
typically characterized by a central barrel formed by parallel
beta-strands surrounded by seven or eight alpha helices, which
isolates the highly reactive radical species in a deep hydro-
phobic cleft at the center of the protein, reducing the
occurrence of unwanted side reactions with solvent. However,
an equally important task requires the enzyme to assume strict
control over the radical intermediates themselves, to suppress
side reactions and protect the interior of the protein from
damage.
Understanding how AdoCbl-dependent enzymes control and
manipulate transient radical species with high fidelity is a
subject that has received less attention when compared to other
aspects of the catalytic reaction, such as the origin of the >1010-
fold rate enhancement of Co−C bond homolysis or the extent
to which homolysis is coupled to hydrogen abstraction.
Nevertheless, various contributions from both experi-
ment5,10−12 and computation13−17,19 have provided valuable
insights that help to better understand the elusive nature of the
5′-deoxyadenosyl radical moiety (for a review, see ref 20) and
its journey to the substrate. Of relevance to these issues are
studies that describe various conformations of Ado· that may be
important to catalysis as well as the roles of nearby amino acids
with which it may interact. For example, potentially important
conformational changes include a pseudorotation of the
glycosyl moiety, reported in diol dehydratase,7 a puckering of
the ribose moiety, seen in GM,8 and an adenine-ribose rotation
about the glycosidic bond in MCM.13,21 Previous theoretical
studies on certain conformational changes in the adenosyl
moiety, such as ribose puckering, attribute the changes in
geometry to strain induced from the bound configuration.6
Other findings from the crystallographic structure22 of MCM
suggest that Ado· adopts the syn conformation (in the Pullman
notation23), when bound to cobalamin and the anti
conformation, when the AdoCbl bond has ruptured.13
Consistent with this finding is the 8,5′-cyclic structure,24
formed via the intramolecular interactions of the C5′ atom with
position 8 of adenine. This conformation was inferred from
previous experiments of tritium labeled H2O which exchanges
with the H8 atom of adenosine
25 (see Figure 1a), whereas
stabilizing intermolecular interactions may involve co(II)-
balamin,26 acting as the “conductor” to lower the transition-
state energy barrier for radical formation and rearrangement,
B12:C19−H, interacting with the O3′ of the ribose moiety of
Ado·,27,28 or a conserved glutamate residue (E370 in MCM,29
E330 in GM,8 and E338 in ornithine 4,5-aminomutase
(OAM)30).
However, despite the many valuable contributions, piecing
the various findings together to formulate a clear picture that
establishes the key factors responsible for reaction selectivity of
the radical intermediates has not been possible. Ultimately,
utilizing the AdoCbl cofactor requires finding a delicate balance
between stabilizing Ado· while still preserving its reactive
nature. Missing from the current understanding are the inner
workings of the enzymatic reaction mechanism that achieve
such a balance, and, in particular the role the enzyme
environment plays in asserting strict control over Ado· during
catalysis. In particular, understanding how and why the enzyme
manipulates conformations of Ado· during the catalytic cycle as
a possible mechanism to ensure selectivity deserves further
attention. This contribution addresses not only the initial
generation of the radical species but especially the further fate
Figure 1. Adenosylcobalamin cofactor. In (a), the B12 cofactor, doubly
coordinated with a histidine residue (DMB-off conformation) and the
5′-deoxyadenosyl moiety (Ado). In (b) and (c), the crystal structures
of bound (pdb entry 3REQ) and unbound Ado (pdb entry 4REQ),
respectively, demonstrate the change in conformation of the adenine
base relative to the B12 corrinoid ring.
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of the 5′-deoxyadenosyl radical moiety throughout its journey
prior to hydrogen abstraction from the substrate. Studying the
catalytic mechanism of MCM, we find that the enzyme acts as a
mechanochemical switch to manage conformational changes in
Ado· by imposing or releasing strain at distinct stages of the
catalytic cycle to effectively channel the reaction in a desired
direction. Interestingly, this switch can either be deactivated
through homolysis or activated through intermolecular
interactions between the 5′-deoxyadenosyl radical moiety and
the protein. Using key conformational changes of Ado· as a
transformational trigger suggests that such a mechanism may be
inherent in other AdoCbl-dependent enzymes.
■ COMPUTATIONAL METHODS
All classical molecular dynamics (MD) simulations were carried
out using the AMBER suite of programs.31 Starting from a
model made from two crystal structures of MCM (pdb entries
1E1C and 3REQ), modifications, such as the mutation A244H,
were made to recover the wild-type sequence of MCM.
Nonstandard residues (B12, Ado, His610 and the substrate,
methyl malonyl-CoA and lactoyl-CoA) were parametrized
using the AMBER 99sb force field32 by following the modeling
of cobalt corrinoids from previous studies.33 The particle mesh
Ewald (PME) method, with a nonbonded cutoff of 12 Å, was
used with periodic boundary conditions and the Langevin
piston Nose−́Hoover method34,35 to ensure constant pressure
and temperature conditions. Classical MD trajectories were
performed for 100 ns before the structures were used to
initialize the QM/MM simulations. For the QM/MM
simulations, we used an extension of Car−Parrinello molecular
dynamics (CPMD 3.13)36,37 to run Born−Oppenheimer
molecular dynamics (BOMD) using a time step of 10 au and
a fictitious electron mass of 400 au. We described the QM
atoms by the DFT/BLYP functional38,39 and norm-conserving
Martins-Trouiller pseudopotentials40 with dispersion-corrected
atom-centered potentials.41 The accuracy of BLYP to describe
the structural and electronic properties of cobalamins has been
previously reported.42 Moreover, the electronic structure and
mechanism of cobalamin and adenosylcobalamin-dependent
enzymes has been extensively studied using similar meth-
ods.43−45 We included 123 atoms in the QM subset, which
consists of the coordinating histidine residue (H610), capped
with a monovalent pseudopotential46 at the beta carbon, the
entire 5′-deoxyadenosyl radical moiety (Ado), the cobalt corrin
ring, capped at the COMe and NHMe side chains, and the
substrate, in which the CoA tail has been capped at the second
carbon after the sulfur atom. The wave functions were
expanded in a plane wave basis set with a 70 Ry cutoff inside
a orthorhombic quantum box with dimensions 23.2 × 29.5 ×
21.6 Å3. This cutoff has been shown to achieve a good
convergence of energies and structural properties of cobalt
complexes in previous studies on vitamin B12.
45,47 In addition,
we found that increasing the cutoff to 95 Ry does not result in
significant changes in relative energy (see Supporting
Information). Long-range interactions of the QM part were
decoupled using the Martyna-Tuckerman scheme.48 The MM
subset was characterized by a classical AMBER 99sb force field
and contained the rest of the protein and explicit solvent water
molecules and 20 Na+ counterions for system neutrality. The
QM/MM simulations were performed at constant pressure and
temperature, using the Nose−́Hoover thermostat. The system
was equilibrated for 20 ps before performing thermodynamic
integration.49 Using constrained BOMD, the reaction coor-
dinate was fixed in increments of 0.1 Å from 2.1 to 3.6 Å to
cleave the Co−C bond over a period of 30 ps. Upon cleavage of
the Co−C bond, the system was further equilibrated for 15 ps
before the hydrogen abstraction reaction took place, using a
similar protocol. The second step is characterized by a reaction
coordinate that describes the distance between the C5′ atom on
Ado· and the primary hydrogen atom on the substrate,
spanning distances of 4−1.1 Å in increments of 0.1 Å. Another
reaction coordinate used to characterize hydrogen abstraction
was the distance between the C5′ atom of adenosyl and the
tertiary hydrogen on the subsequent carbon atom (H3°).
Additionally, we explored the rotation of the adenine base
about the glycosidic bond (ϕ = O4′−C1′−N9−C8, Figure 1b),
increasing the reaction coordinate (ϕ) from ∼50 to 100° in five
windows with increments of ∼10°. Hysteresis was evaluated by
performing the back reaction for both homolysis and
abstraction steps. Gas phase calculations were performed
using Gaussian ‘09 (G09).50 Optimizations and relaxed scans
were performed at different levels of theory, including DFT and
MP2 and with various basis sets.51 For more details see the
Supplementary Methods.
■ PREPARATION OF MCM ACTIVE ENZYME
Propionibacterium shermanii mutB and mutA genes which code
for the α subunit and β subunit, respectively, were codon-
optimized for expression in Esherichia coli and synthesized using
standard algorithms (Life Technologies/Thermo Scientific/
Fisher). The genes were ligated into pETDuet-1 (Novagen)
and with an N-terminal His-tag on the mutA product. Purified
and sequenced construct was transformed into BL21 DE3
chemically competent cells and expressed using approaches
from previous standard procedures52,53 with minor alterations,
such as the addition of a 10 min, 42 °C heat shock step prior to
induction. The cells were pelleted and lysed using known
procedures, except that an additional cell lysis step was
performed on the initially retrieved cell pellet. Appreciable
amounts of soluble protein were detected in both cell lysate
solutions (from first and second pelleting), and thus the lysate
was pooled and exchanged with dialysis into 50 mM potassium
phosphate buffer, pH 7.5, overnight at 4 °C. The protein was
purified with 6x-His affinity Ni(II) binding resin (Qiagen,
Hilden, Germany). Protein was then reconstituted overnight
with 5′-deoxyadenosyl-cobalamin (Sigma-Aldrich, St. Louis,
MO) under reduced ambient light. Excess cofactor was
removed with a P-30 spin column (BioRad, Hercules, CA).
■ ASSAY OF MCM ACTIVITY
MCM was assayed by Accurate-Mass Q-TOF LC/MS (Agilent)
using adaptations of published methods to analyze the presence
of CoA esters. Purified protein (5 μg), previously reconstituted
with cofactor, was inoculated with substrate (methylmalonyl-
CoA, 0.1 mg) and run for several time points as well as
overnight at 37 °C and in the dark. Ten microliters of each
reaction was injected for analysis, and the mass spectrometry
peaks for methylmalonyl-CoA were integrated and analyzed
against a standard curve constructed of five different substrate
concentrations (software Agilent Mass Hunter Acquisition and
Q-TOF Quantitative Analysis). For more details, see the
Supporting Information.
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■ RESULTS AND DISCUSSION
Conformational Changes That Accompany Cleavage.
Homolysis demands the scission of the kinetically inert AdoCbl
bond to initiate radical chemistry. One of the main challenges
at this step in the catalytic cycle is to prevent recombination
from occurring in order to transfer the radical to the substrate.
To probe the functional relationship between cofactor, enzyme
and substrate during the homolytic cleavage reaction, we
studied the catalytic cycle of MCM using both classical and
quantum mechanical/molecular mechanical (QM/MM) Car−
Parrinello37 molecular dynamics (CPMD) simulations.
The choice of starting structure for the classical MD
simulations was selected to embody the characteristics of the
AdoCbl cofactor before homolysis. Various crystallographic
structures of MCM reveal different orientations of the 5′-
deoxyadenosyl radical moiety, which appear to differ based on
whether the Co−C bond is formed or broken. When AdoCbl is
in the bound state (Co−C < 2.5 Å), such as for pdb entry
3REQ,12 the enzyme is referred to as the open and unreactive
state, and the conformation of the adenine ring is said to be
syn.13 In this state, the adenosine base is in a position that is
parallel to the corrinoid ring, typically constrained by two side
chains of the B12 pyrrole ring B. Characteristic of this
conformation is a value for the glycosidic dihedral angle (ϕ =
O4′−C1′−N9−C8, Figure 1b) greater than ∼90°. In contrast, in
the unbound state of AdoCbl (Co−C >3.5 Å), such as for pdb
entries 4REQ12 and 2XIQ,54 Ado· adopts the anti conformation
in which the adenosine base is perpendicular to the corrin ring
(Figure 1c and Supplementary Figure 1, Supporting Informa-
tion). The value of ϕ in this conformation is in the range of
45−55°. These distinct conformations of Ado· are consistently
observed in crystallographic structures of other AdoCbl-
dependent enzymes (Supplementary Table 1, Supporting
Information), such as GM (pdb entry 1I9C8) and OAM
(pdb entry 3KOZ55).
It has been previously suggested that the AdoCbl-dependent
proteins undergo large-scale conformational rearrangements
upon binding to the substrate,19 which signals the importance
of selecting a starting structure in complex with a substrate.
Taking these observations into consideration, we began the
MD simulations using a structure in the closed (reactive) state
and with an intact AdoCbl bond. Insertion of the 5′-
deoxyadenosyl moiety from 3REQ into pdb entry 1E1C22
gave a model with MCM in the closed state (in complex with a
desulfo coenzyme A ester, in which the terminal acyl and sulfur
groups have been removed) and a final representation of
AdoCbl in a “base-off”, hexa-coordinated, “bound” co(III)-
balamin state (a Co−C bond length of 2.1 Å) with the adenosyl
group in the syn conformation and the ribose moiety adopting a
C3′-endo conformation. Our QM/MM model shows good
agreement with the open (reactive) state of the enzyme, and a
comparison can be found online in Supplementary Figure 2 and
Supplementary Table 2, Supporting Information. Starting the
QM/MM simulations from the classically equilibrated
structure, we chose to describe homolytic cleavage with the
C5′···Co distance as the designated reaction coordinate. The
free energy barrier determined from thermodynamic integra-
tion49 (TI) was 12.4 ± 1.9 kcal mol−1, in good agreement with
estimates from kinetic experiments as well as computational
simulations (13.1−15.3 kcal mol−1).6,10,14,15
Cleavage of the glycosidic bond induces a significant
molecular event as a result of the formation of the radical
intermediate, Ado·. After removing the constraint on the
reaction coordinate at 3.6 Å, Ado· diffuses 3 Å from its original
binding position, out of the cavity proximal to the B12 pyrrole
ring B. This relieves the adenosine base from a previous,
sterically confined configuration (syn) and allows for its
Figure 2. Mechanochemical switch. Upon homolysis, illustrated by the stages 1a to 1b, Ado· diffuses out of its cavity and undergoes a spontaneous
conformational change in which the adenine base rotates by 100° to an orientation perpendicular to the corrinoid ring. The hydrophobic and
nonpolar residues lining the cavity around the adenine base allow for this rotation to be diffusion controlled. The panel on the upper right displays
the free energy profile for Co···C5′ bond cleavage. In contrast, during the hydrogen abstraction reaction, illustrated by the stages 2a to 2b, the enzyme
mediates the conformational change in Ado· from C3′-endo to C2′-endo via nearby charged and polar residues which exchange hydrogen bonds with
axial O3′ and equatorial O3′. The panel on the lower right displays the free energy profile for hydrogen abstraction. The maximum error obtained
along the profiles are indicated by the error bars.
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rotation of nearly 100° about the glycosidic bond (Supple-
mentary Video 1, Supporting Information and Figure 3), which
orients the base orthogonal to the corrinoid ring (1a versus 1b
in Figure 2). Our findings indicate that Ado· adopts this anti
conformation (ϕ = 47° ± 23.5), within 5 ps after homolysis at a
Co−C bond length of 4.6 Å. This state is stable during 10 ps
and is consistent with crystal structures in which AdoCbl is in
the unbound state11,22 (see Supplementary Figure 2 and
Supplementary Table 2, Supporting Information).
Intramolecular Stabilization Mechanism of 5′-Deoxy-
adenosyl Radical. Our findings suggest that the rotation of ϕ
from >90° to ∼47° fulfills two distinct purposes, which we
describe below: (i) it stabilizes the radical intermediate and
thereby prevents deleterious side reactions from occurring, and
(ii) it is one of the factors shifting equilibrium in favor of radical
propagation instead of recombination. To address the first
point, this conformational change brings the C5′ radical center
within 3 Å of the hydrogen atom (H8) on the C8 atom. This
stable conformer supports the previous suggestion that
intramolecular stabilization of Ado· yields a configuration
similar to the 8,5′-cyclic structure.24 The formation of the 8,5′-
cyclic structure is reported to be strongly exothermic (by 10−
20 kcal mol−1)21 with the lowest transition state lying at about
10 kcal mol−1. We find the barrier for abstraction of the H8
atom to be kinetically noncompetitive to the native reaction
(4.0 ± 0.5 kcal mol−1 higher than the native hydrogen
abstraction reaction, see Supplementary Figure 4, Supporting
Information). Thus, rotation of ϕ leads to a stable
conformation of Ado·, which secures its reactivity during its
journey to the substrate. These findings naturally lead to the
question: does the enzyme guide this conformational change or
simply host it?
To answer this question, we carried out gas phase
calculations to discern whether or not the rotation of ϕ is
favored in the absence of the protein environment. Starting
configurations of Ado· were taken from the QM/MM
simulations and from various crystal structures in both the
“bound” (ϕ > 90°) and “unbound” (ϕ = 45−55°) states.
Geometry optimizations converge to a single, stationary
minimum (ϕ = 48°) with the adenosine base in a similar
orientation (anti) to that of the “unbound” Ado· in the protein
environment. A scan of ϕ reveals additional minimum energy
conformers, consistent with those found in a previous
computational study,21 corresponding to stationary minima
with ϕ angles of 48°, −11°, and −110° (−4.8, −13.6, and −7.0
kcal mol−1 lower in energy than ϕ > 90°; see Figure 3a and
Supplementary Figure 5 and Supplementary Table 3,
Supporting Information). Our findings are consistent with
those from another study,19 which suggest that the rotation of
ϕ from its original position (ϕ > 90° and parallel to the
corrinoid), stabilizes Ado· by nearly 5 kcal mol−1 (see Figure
3a). These findings are in agreement with Ado· conformational
changes in other AdoCbl-dependent isomerases,21 which may
accompany and possibly facilitate the scission of the AdoCbl
bond. In comparison to these gas phase calculations, we
computed a free energy estimate for the syn to anti transition
(ϕ from ∼47° to 90°) in the unbound state and in the enzyme
environment to be 8 kcal mol−1.
Therefore, the results from gas phase calculations indicate
that this conformational change is intrinsic to Ado· and
independent of the enzyme environment. Indeed, a chain of
mostly small and hydrophobic residues (L374, P375, Y89, A90,
G91, V115, and A116) lines the cavity surrounding the
adenosine base to allocate enough space for this rotation of ϕ
to occur. Hydrogen bonding with the base occurs only with the
backbone atoms of the protein and is readily transferred from
G91 in the syn configuration to A116 in the anti configuration.
Evidence from crystal structures of various other B12-dependent
enzymes lends further support to the idea that the family
provides an environment that allows for unobstructed rotation
of ϕ to occur. Within the B12-dependent family of enzymes, the
value of ϕ in different crystal structures corresponds to the
values of “bound” and “unbound” Ado· that we observe in
MCM (ϕ ≥ 90°, ∼47°, and −110 to −150° in Figure 3b).
Looking at the active sites among this family of enzymes, we
find that many are lined with small, hydrophobic residues
similar to those found in the vicinity of the adenine base in
MCM (1b in Figure 2). Having available space in the active site
as well as nonpolar and uncharged residues in the vicinity of
Ado· may be two important factors enabling this conforma-
tional change.
Apart from these hydrophobic interactions, a polar contact
stabilizes Ado· in the form of hydrogen bonding interactions
between the O4′ atom of Ado· and a nearby residue, Y89. This
so-called “aromatic wedge” residue is ascribed to accelerate
AdoCbl bond homolysis and has been proposed to directly
influence the formation of the radical species.5,12 Our
Figure 3. Different conformations of Ado· in other B12-dependent
enzymes. In (a), the results of a relaxed scan in gas phase along
glycosidic bond, the O4′−C1′−N9−C8 dihedral angle, of an isolated
Ado· moiety. The scan uncovers several free energy minimum
structures: ϕ of 48, −11, and −110°. All energies (M06/6-31G(d)) are
relative to an arbitrarily chosen origin, an orientation of Ado· taken
from the QM/MM simulations following AdoCbl bond cleavage (an
averaged value of ϕ of 115° ± 8.9). Performing a geometry
optimization of Ado· from this bound state gains nearly 5 kcal
mol−1 of energy via the rotation of ϕ from 115° to 48° (indicated by
the dashed gray line connecting these two points). In (b), the ϕ values
taken from various B12-dependent enzymes, plotted as a function of
AdoCbl bond length. The gray points represent the average dihedral
value for each cluster. When bound to Co(III), the value of ϕ is 50−
80° larger than it is in the unbound state. As previously suggested,21
the global minimum structure in the gas phase (ϕ = −11°) is stabilized
by an intramolecular hydrogen bond between H−O2′ and N3, which is
not observed in the condensed phase.
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simulations reveal that a flexible movement of Y89 accom-
modates the rotation of ϕ from >90° to 48° and then allows for
a strong hydrogen bond to form with Ado· (1.6 Å, see
Supplementary Video 1, Supporting Information). This
observed interaction between Y89 and Ado· may also explain
why recombination of the AdoCbl bond is favored in the Y89F
mutant despite minimal differences in structure between
mutant and wild-type enzyme.5
Conformational Changes That Accompany Hydrogen
Abstraction. After cleavage of the Co−C bond has taken
place, the diffusion of Ado· from the cavity together with the
rotation of ϕ (>90° to 17−47°) guides the C5′ radical center to
a location within 4 Å of the substratean ideal starting
platform to initiate the hydrogen abstraction reaction. At this
site, Ado· is positioned among several charged and polar amino
acids situated 7−10 Å from cobalamin center (E247, Y243,
Q330, and N366). Hydrogen bonding interactions between
these residues and the O2′, O3′ atoms and their respective
hydrogen atoms of the ribose moiety secure its positioning at
this site in the protein. These findings are consistent with
crystallographic structures that capture AdoCbl in the “un-
bound” state (4REQ).22 However, the proper positioning of
Ado· alone does not prevent the radical intermediate from
undergoing deleterious side reactions with the substrate.
Because hydrogen abstraction from an unactivated primary
carbon atom requires a high level of specificity, side reactions
with lower energy barriers and/or products that are
thermodynamically favored are highly competitive. For
example, Ado· must be selective enough to discern a primary
hydrogen atom (H1°) from the tertiary hydrogen atom (H3°)
bound to the subsequent carbon atom on the substrate (Figure
4a). The latter leads to a more thermodynamically stable radical
intermediate and would not induce a 1,2-rearrangement
reaction.
How the enzyme manipulates and controls the transient
Ado· moiety was investigated using QM/MM simulations.
Starting from the cleaved structure, we investigated the
hydrogen abstraction reaction using the distance between the
C5′ atom and the nearest H1° atom on the substrate as reaction
coordinate. The free energy barrier for abstraction is 11.3 ± 0.3
kcal mol−1, in agreement with other computational studies.15,16
However, the rate of the hydrogen transfer can be expected to
increase by at least 1 or 2 orders of magnitude due to quantum
tunneling effects.17,18 We also investigated the barrier of
abstraction in the absence of the rotation of ϕ in Ado· and
found that, without this conformational change, the barrier
increases by 6.0 ± 1.0 kcal mol−1 (see Supplementary Figure 4,
Supporting Information). These findings further suggest that
the intramolecular stabilization mechanism of Ado· is a required
transformation that procedes hydrogen abstraction and
apparently sets the stage for other crucial conformational
changes to take place.
During hydrogen abstraction, a second, key conformational
change in Ado· preempts the transfer of the radical to the
substrate. At a C5′···H1° bond distance of 1.9 Å, we observe a
spontaneous change in the puckering of the ribose moiety from
C3′-endo (2a in Figure 2) to C2′-endo (2b in Figure 2 and
Supplementary Figure 6, Supporting Information). At this point
in the reaction, the C5′ atom and the H8 atom approach an
interatomic distance of 2.7 Å before the conformational change
to C2′-endo occurs. Just before this transition takes place, the
adenosine base toggles between H1° and the C5′ atom (see 2b
in Figure 2), which brings the C5′ radical center into a position
that is equidistant from both the H1° and the H8 atoms (Figure
4b and Supplementary Figures 6 and 7, Supporting
Information). The transition to the C2′-endo conformer
radically manipulates and constrains the geometry of Ado·,
forcing the C5′ atom to orient away from the H8 atom and
toward H1°. This spontaneous transitioning between states is
consistent with gas phase calculations, which indicate that the
C2′-endo conformer is only slightly lower in energy than its
counterpart (1.5 kcal mol−1). These two distinct conformations
of the ribose moiety of Ado· are also in agreement with the
experimentally observed “ribose pseudorotation” in the
crystallographic structure of glutamate mutase.8
A Mechanism to Control the Selectivity of 5′-
Deoxyadenosyl Radical. Previous findings suggest that the
C2′-endo conformer rigidly confines the trajectory of the C5′
atom and directs the radical center toward the hydrogen atom
Figure 4. Preventing unproductive side reactions. Using QM/MM
simulations, the free energy profiles for the native hydrogen (H1°)
abstraction and a deleterious side reaction, the abstraction of the
tertiary hydrogen atom (H3°) on the subsequent carbon atom, are
shown at the top. In the native reaction mechanism, shown in green
and labeled b, the shift in ribose puckering of the Ado· moiety from
C3′-endo to C2′-endo occurs spontaneously during the hydrogen
abstraction step and is accommodated by MCM via a nearby glutamate
residue, E370. In the absence of this conformational change, the Ado·
remains in the C3′-endo conformation, and the abstraction of the
“wrong” hydrogen atom (in this case, H3°) is thermodynamically and
kinetically favored over the native reaction (see purple curve, labeled
a). In contrast, abstraction of the same hydrogen, H3°, is no longer
favored if Ado· adopts the C2′-endo conformation (see orange curve
labeled c).
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to be abstracted.8 Our QM/MM simulations provide further
evidence of this proposal and present additional details that
clarify why this conformational change is crucial in upholding
the selectivity of Ado·. We find that specific enzymatic
interventions have evolved to prevent certain configurations
of Ado· that might lead to erroneous side reactions with the
substrate. One such configuration that is blocked by the
enzyme during hydrogen abstraction is that of the C3′-endo
conformer of Ado·. Without the change in ribose puckering to
the C2′-endo conformer, the abstraction of the H3° atom from
the substrate is found to be strongly competitive with a barrier
for abstraction of 9.0 ± 0.2 kcal mol−1 (Figure 4a). This
unproductive alternative would be both kinetically and
thermodynamically favored over the native abstraction reaction.
Fortunately, the enzyme is actively involved at this point in
the reaction to prevent such mistakes from occurring.
Evidently, the enzyme is “spring-loaded” in a conformation in
which functional groups are positioned to accommodate one
particular conformer, depending on the distinct stage of the
catalytic cycle. For the initial C3′-endo geometry, Y243 and
Q330 hydrogen bond to the H−O3′ and O3′ atoms of the
ribose moiety. Upon transitioning to C2′-endo geometry, the
enzyme provides the H−O3′ atom with a substitute hydrogen
bonding partner, E370, capable of accommodating its newly
equatorial position (Figure 4b, Supplementary Figure 8 and
Supplementary Video 2, Supporting Information). This change
effectively constrains the C5′ radical center and reduces the
likelihood of Ado· abstracting the “wrong” hydrogen atom. By
reinforcing the conformational switch of C3′-endo to C2′-endo,
the barrier of abstraction of the H3° atom increases by 4 kcal
mol−1 (to 14.0 ± 0.8 kcal mol −1) and is no longer competitive
to the native abstraction of the H1° atom (Figure 4c).
It has recently been shown that mutation of this conserved
glutamate residue, denoted E370 in P. shermanii, to aspartate in
OAM (E338D) and human MCM protein (E338D) generates
mutants with 380- and 60-fold reductions in catalytic
turnover30 (see Supplementary Figure 9, Supporting Informa-
tion for a comparison of active site residues). To be sure that
the same behavior is also observed for the system studied in this
contribution, site-directed mutagenesis experiments were
carried out for the enzyme present in P. shermanii. We find
that the mutation E370D reduces the catalytic activity by 50-
fold relative to the wild-type MCM activity, which is in good
agreement to the above studies (see Supplementary Figures 10
and 11, Supporting Information). Taken together, these
findings indicate that the mutation of this conserved residue
drastically reduces catalytic turnover in the mutant enzyme. It
has been proposed that the glutamate residue plays a role in
controlling the initial generation of the radical species.30
However, on the basis of our computational findings for this
mutant (Supplementary Figure 12, Supporting Information) as
well as a detailed comparison of various crystallographic
structures (Supplementary Table 2, Supporting Information),
it seems more likely that, in the case of MCM, the main role of
this residue is in the control of the hydrogen abstraction step.
Activating and Deactivating the Mechanochemical
Switch. Our findings suggest that a mechanochemical switch is
activated or deactivated at distinct stages of the catalytic cycle
to control the highly reactive nature of Ado·. During the first
catalytic step, spontaneous changes in the conformation of
Ado· accompany cleavage via a rotation of ϕ from >90° to 47°.
We suggest that this conformational change favors the forward
propagation of radical species in two distinct ways: (i) the
stability of Ado· increases by means of favorable intramolecular
interactions, and the formation of a strong hydrogen bond
between Ado·:O4′ and Y89 and (ii) sets the stage for other
crucial conformational changes in Ado to take place during the
hydrogen abstraction step. Thus, at this stage in the catalytic
cycle, the enzyme is an exemplar of a passive control element
(i.e., the switch is turned “off”) and provides a conducive
environment for the intramolecular stabilization of Ado· to take
place. The fact that the enzyme uses a “preprogrammed”
technique to control Ado· is evidenced by the spacious
hydrophobic cavity available to Ado· upon diffusion out from
its binding site. This hydrophobic cavity permits the radical to
adopt an unreactive conformation while it diffuses through the
protein.
In contrast, during the second step of the catalytic cycle, the
enzyme acts as an active control element, in which the
mechanochemical switch is turned “on”. At this point in the
cycle, the control of Ado· involves direct manipulation of the
ribose geometry. Changes in puckering from C3′-endo to C2′-
endo are induced by nearby polar and charged residues, which
effectively transfer hydrogen bonding interactions from the H−
O3′ atom in an axial position to its equatorial counterpart.
Unlike the first step, the function of this second conformational
change is less about the stabilization of Ado· and more about
manipulating the orientation and steric properties of the radical
species to prevent deleterious side reactions. We have shown
that the abstraction of a tertiary hydrogen atom (rather than the
proper primary hydrogen atom) of the substrate can be avoided
via this conformational change.
■ CONCLUSIONS
Dealing with radical intermediates is an extremely demanding
task, requiring the assemblage of different control tactics. In the
case of AdoCbl-dependent enzymes, nature has found a way to
utilize an exceptionally effective mechanochemical switch,
which is activated and deactivated at specific stages during
the catalytic cycle to gain control of reactive intermediates.
Depending on the intrinsic or extrinsic factors during the
catalytic cycle, the switch can either be turned “off” to utilize
internal strain and stored energy via spontaneous conforma-
tional changes in Ado· or “on” to utilize the enzyme
environment as the driving force for propelling forward a
desired chemical task. This mechanochemical switch illustrates




Further details of the procedures used to model MCM, perform
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4. Bacillus subtilis Oxalate Decarboxylase
4.1 Introduction
Oxalate Decarboxylase has been called an enigmatic enzyme because all measure-
ments that can be made on OxDc are made more complex by the presence of two,
nearly identical active sites in each monomer. This chapter introduces OxDc and it’s
substrate oxalate in a biological context while highlighting controversial background
information. As in previous chapters, more methodological detail is include at the
end of the chapter. Some subjects are introduced here to place the importance of
this enzyme and this reaction in context. The Results and Discussion begins with
the experiment designed to approach the problem of disambiguating the two nearly-
identical active sites, and continues from there.
4.1.1 The Substrate Molecule: Oxalate in Biology
The molecule oxalate is found ubiquitously in nature, particulary in soil and rock
deposits, as biominerals, and as deposits in animal tissues. Naturally occuring ox-
alate is often found in complex with organic or metal ligands. [45] Human beings
do not directly possess any way to catabolize oxalate which is consumed from the
diet, although a bacteria Oxalobacterformigenes, found in the gut flora of the hu-
man small intestine, can metabolize oxalate. Further, there is a hypothesis that the
lack of oxalate-catabolizing bacteria may present the opportunity for kidney stone
formation, which follows because kidney stones are generally composed of calcium
oxalate and other types of insoluble calcium salts. [46, 47] OxDc has been proposed
as a treatment for the enzymatic, in vivo, dissolution of kidney stones, an application
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Figure 4.1. The Reactions of Oxalate Degrading Enzymes
which would greatly improve upon the current mechanical treatments for removing
kidney stones. In fact, it has been shown in rats that oxalate decarboxylase producing
bacteria (administered as a probiotic) reduces the incidence of kidney stones, even
when dietary oxalate levels are quite high. [48,49]
4.1.2 Oxalate Degrading Enzymes
Oxalyl-Coa Decarboxylase
Oxalyl-CoA Decarboxylase (OCD) is found in the bacteria Oxalobacter formi-
genes, an inhabitant of the human digestive tract. [50] Although OCD is an impor-
tant part of oxalate metabolism in humans, it is actually more closely related to
Acetolactate Synthase, an enzyme involved in amino acid synthesis. [51] Oxalyl-Coa
Decarboxylase, like Acetolactate Synthase, is a thiamin dependent enzyme and thus
is not related mechanistically to Oxalate Oxidase or Oxalate Decarboxylase, and will
thusly not be further discussed.
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Oxalate Oxidase
Oxalate Oxidase (OxOx) is an enzyme which catalyses the conversion of oxalate
and dioxyen into carbon dioxide and hydrogen peroxide (Figure 4.1). The production
of hydrogen peroxide by OxOx plays a role in plant-pathogen interactions. [52] OxOx
structures with glycolate bound indicate that superoxide anion driven carbon-carbon
bond cleavage is the likely mechanism. This mechanism would require both oxalate
and dioxygen to be bound monodentate. In ths reaction, Mn is therefore acting as a
kinetic tether to hold oxygen and oxalate in proximity to one another as well as an
oxygen reductant. [53,54] The active site of OxOx looks strikingly similar to OxDc -
both enzymes exhibit cupin folds and both enzymes bind Mn exclusively. Although
no further discussion regarding OxOx will be included in this thesis, comparative
studies between the two proteins are of merit and interest for future studies.
Oxalate Decarboxylase
Oxalate Decarboxylase (OxDc), one of three oxalate degrading bicupin enzymes,
degrades oxalate into formate and carbon dioxide, and appears to use O2 as a cofactor
(Figure 4.1). Oxalate Decarboxylase is a well-studied enzyme for which the literature
spans nearly six decades, with particular scrutiny in the last ten years. [21, 55–70]
The role of O2 in the OxDc catalyzed reaction remains controversial, as some sub-
stochiometric oxygen appears to be consumed, and an equivalent amount of peroxide
produced. This may be explained by some mechanistic ”leakage” which allows OxDc
to act like closely related oxygen-degrading enzyme, Oxalate Oxidase, but the mech-
anism of such a reaction is unclear. The mechanism of this enzyme is not known,
although two notable mechanistic hypotheses exist in the literature. [65, 68]. OxDc
crystallizes as a hexamer [55], but the biological relevance of the crystallographic
hexamer formed by six monomers of Oxalate Decarboxylase has been a point of con-
tention in the field.
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4.1.3 Manganese and Metalloenzymes
Manganese(Mn) is an amazing biological cofactor which has special electronic
properties such as a certain reduction potential;
Mn3+ + 1e− →Mn2+ 1.5 eV (4.1)
which may be perfect aligned for reactions which require this potential. Manganese,
compared to other biological metals such as Copper, is actually far more abundant
than it’s biological usage would suggest. There are, compared to Iron, Copper and
Zinc, fewer Manganese dependent reactions in biology (although in some cases Mn
can substitute and offer a reduced activity in promiscuous enzymes for the native
metal). [71]
Manganese is a cofactor in some enzymes, and, with the exception of Oxalate
Decarboxylase, is only included exclusively in enzymes which depend on Mn for oxi-
dation/reduction chemistry. Enzymes that use Mn, either tightly or ”weakly” bound,
include Pyruvate Carboxylase, Phosphoenolpyruvate Carboxykinase, Superoxide Dis-
mutase, Glutamine Synthetase, Arginases, Catalases, various DNA polymerases, the
oxygen evolving complex (OEC) of Photosystem II, Dioxygenases, Acid Phosphatases,
and Oxalate Decarboxylases (the subject of this chapter). In Oxalate Decarboxylase,
the literature suggests that this cofactor does not undergo oxidation-reduction in any
formal sense, and is merely a tether for various ligands along the course of the decar-
boxylation reaction. If this is true, this enzyme would be the only tightly Mn binding
enzyme that does not undergo redox chemistry.
4.1.4 Inorganic Chemistry of the Mn2+ Cofactor
Manganese, as found in OxDc, has been proposed to be in the 2+ oxidation state
based on EPR data. Other oxidation states of Mn are possible, but will be discussed
in the results as there is no such discussion in the current literature. Mn2+ is high
spin, with a d5 electron configuration, meaning that there are five unpaired electrons.
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Figure 4.2. OxDc Monomer, with clear demonstratoin of bicupin fold,
two Manganese metal binding sites and metal binding residues
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Mn2+ forms much weaker complexes than similar biological ions, such as Fe2+, Fe3+,
or Cu2+, because the Mn2+ ion is very nearly spherically symmetric (in the ground
state). [72]
Zero-Field Splitting in Mn2+
Mn2+ is considered to have S-state character in free solution, that is that the
electron distribution is quite evenly laid in a spherical shape around the Mn nucleus,
so it can be imagined as a quite large S-orbital. In fact, Mn as a free ion is beautifully
symetrical, with each of 5 elecrons occupying each of the d-orbitals. When Mn is
found in condensed phases and is interacting with ligands, this perfect degeneracy is
removed as is the perfect S-state character. Thus, the dz2 and dx2−y2 orbitals (eg)
orbitals are at a higher energy than the dxy, dxz, dyz orbitals (t2g) orbitals.
The eg and t2g orbitals are separated by an energy difference (∆), which is a
function of the ligands themselves and thus is called the ligand field splitting energy.
This splitting determines whether a metal may be high spin (HS) or low spin (LS).
Ligands which are considered strong field ligands push this ligand field splitting energy
to larger values, such that a LS state is created. Ligands which are weak field ligands
maintain a smaller ligand field splitting energy which allows Hund’s rule to be fulfilled
and for electrons to be placed into all five orbitals before pairing electrons into the
same orbital (HS). Mn is in most cases, and in the case of Oxalate Decarboxylase
found to be HS.
More Ligand-Induced Phenomena in Mn2+
Mn is altered by ligands in more ways that simply the degeneracy and energy of
it’s d-orbitals. There is imposed a balance between repulsion giving rise to electro-
static interactions (ligand electron and metal electron) and attraction giving rise to
”covalent” forces (ligand and metal electrons and metal nucleus). These interactions
can give rise to altered shapes in d-orbital electron density. This is referred to as
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zero-field splitting, named such as it occurs in the absence of any applied magnetic
field. This splitting is present, but minimized, at geometries nearest perfect a perfect
octahedron. As a structure deviates further from this octahedron, the zero-field split-
ting is increased, and for Mn(II), is cubic in nature. This is further increased by the
presence of multiple types of ligands (which is the case in the metalloenzyme Oxalate
Decarboxylase).
ZFS in Mn may are contributed to by Spin-Orbit Coupling which is observed
in Mn2+ at Zero-field. As an electron interacts with the nucleus, a magnetic field
is generated. This magnetic field interacts with the spin found on this electron to
produce electromagnetic interactions which further shift the d-orbital energy levels.
This splitting arises from the excited states 4T1,
2T2 and
2E interacting with the
ground state 6A1. [73] Additional splitting of energy levels is a function of the Zeeman
interaction. This is displayed in Figure 4.3. This interaction dominates the EPR
spectra that are shown at high-field, and are used to calculate D and E values, where
as traditional fine and hyperfine structure interactions are present in the X-band (low
frequency) spectra that are used to determine general geometry and oxidation state
of the metals present. Additional theory is included in the Methodology section at
the conclusion of this chapter.
4.1.5 EPR as Applied to the Study of OxDc
Electronparamagnetic Resonance (EPR) can be used to probe the electronic en-
vironment of paramagnetic centers such as those in Mn2+ (and Mn3+). Specifically,
by collecting spectra at a fixed frequency and a modulating field, we can begin to
form an electronic picture, which we interpret by constant values that are derived
to fit equations which model the spectra that we record. At higher frequencies we
can unveil hyperfine structure, which reports upon nuclear interaction with magnetic
fields eminating from the Mn electrons themselves, while lower frequencies suffice for
fine structure determination, which reports upon electron-generated, electron-based
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Figure 4.3. EPR spectra and accompanying energy levels of the a
Mn5/2 ion when Zeeman interactions are dominant over other forces.
Reproduced with permission [58].
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interactions between the ligand electrons and Mn electrons. Because the hyperfine
structure is a function of the nuclear interaction, and the nucleus has a spin of I=5
2
,
there are six lines visible as a function of every hyperfine interaction (magnetic cen-
ters of different spins, such as another ion, would split the signal differently). These
hyperfine interactions are visible within each single peak which represents the fine
structure interactions. (Figure 4.4) The g-values (visible as locations on the magnetic
field) of the various features, when compared with current literature knowledge about
enzymatic Mn cores [58,71,73], can enlighten us further about the crude geometry of
each species and it’s relative abundance in the sample.
4.1.6 Tryptophan Residues of OxDc
Much of the insight necessary to conjecture a new mechanism for Oxalate Decar-
boxylase comes from the consideration of enzyme residues both local to and long-range
from the active site. Of particular interest are conserved tryptophan residues. There
are seven trytophan residues per monomer (Figure 4.9), all of which are conserved,
six of which exist in pairs (Figure 4.5), with W132 being the only trytophan that
exits in one terminus (the N-terminus) and not the other. This amount of trypto-
phan residues is unusually high, comprising about 3% of amino acids in the protein.
Typical occurences for the TGG codon are about 1%, but rates may be higher in
protein-coding nucleic acids. Because the rate of occurence is higher than expected,
this amino acid occurence may be adapted, i.e. evolutionarily selected.
4.1.7 Using Trytophan Residues and EPR to Probe OxDc
Because both active sites are nearly identical, it is very difficult to probe these
active sites via EPR directly. Efforts to express the domains separately have failed,
leaving no way to physically separate the two sites from each other. In fact, a dis-
cussion exists in the literature as to the assignment of the N- and C-terminal active
sites to the proper EPR generated structure parameters. [58,64] Ideally one needs to
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Figure 4.4. The fine structure is reported in this spectra by these
two separate field positions. The variation within each of these field
positions is due to the hyperfine interaction.
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Figure 4.5. All tryptophan residues in OxDc, colored by ”pairs” (red,
blue and orange) and organized by active site association. Metal bind-
ing histidine and glutamate residues (cyan color) are also indicated.
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invent a mutation which will alter the active site of one terminus of the protein, while
leaving the other intact. This starts the story of the W132F mutation and subsequent
studies.Because of the distribution of trytophans and their proposed (and later con-
firmed) role in the catalysis of oxalate by Oxalate Decarboxylase, it is proposed that
fluorinated analogs of tryptophan molecules would alter the catalytic parameters of
the protein.
4.1.8 Improving the Preparation of OxDc in Order to Collect High-Field
EPR Spectra
The largest problem that loomed upon initiation of these studies was with the
quality and concentration of the OxDc protein. For EPR studies in particular, as
well as other magnetic spectroscopic methods such as CD, it is very important to
achieve high-quality and very high-concentration protein during sample preparation.
More details about this type of sample preparation are included in the Methodology
section, but it is worth noting here that almost two years of preparative work on the
enzyme purification and concentration steps were required to obtain spectra of the
quality found in this thesis. These spectra, where even the fine structure is visible,
are the highest quality Mn-containing enzyme spectra to date.
4.2 Results and Discussion
This chapter addresses many independent problems that have thus far been un-
accounted for in the OxDc literature, as well as some problems which have seen con-
tentious argument. These results begin with the attempt to resolve an issue central
to the study of Oxalate Decarboxylase. Because the active sites of Oxalate Decar-
boxylase (N- and C-terminal) are so similar to each other, the spectroscopic data on
each site is overlapping. How do we resolve which active site is which - that is, which
signal is which? Further study of this enzyme is stalled until there is finality on this
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point. Therefore, the first experiment designed on this project was aimed at solving
this perplexing problem.
4.2.1 C-terminal Mutants E280D and R270K
Initial experiments aimed at perturbing the metal binding residues of the C-
terminus were not successful initially. These enzymes incorporated Mn, but at sub-
standard rates, and therefore were not useful as probes of this termini assignment
problem. One can see from the data on these mutants in Table 4.1 that the KM
is extremely high. Otherwise, it is clear that pre-catalytic steps, possibly including
binding, are suffering severely from these mutations. This was the case with E280D,
which is a mutation to the actual metal-binding glutamate in the C-terminus, as well
as, perhaps less severely, with R270K, which is a mutation to an Argininine residue
located near the active site which has a proposed electrostatic role in stabilizing any
substrate (if any) bound to this site. The fact that these mutations did not completely
eliminate Metal-binding to the active site, along with the fact that an electrostatically
important residue appears to be important to this site, gives some evidence that we
should not eliminate the C-terminus as a potential substrate binding site. Regardless
of mechanistic explanations regarding this active site, it is clear that the signicantly
altered kinetic values mean that these mutants require further analysis, but solubility
problems precluded them from being used further for the aim at this point in the ex-
periment. That is, to produce a mutant that is reasonably active and can reasonably
be assumed to perturb one metal-binding site and not the other. This is the role of
the next mutant, W132F.
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Table 4.1.
C-terminal Mutant Steady-state Kinetic Data
Protein KM Kcat/KM/Mn Metal
WT 2±1 9000±100 Mn
R270K 200±10 120±20 Mn
E280D beyond solub. 600±100 Mn
4.2.2 W132F
Experimental Findings
This development of W132F only came after this failure of C-terminal mutants to
produce a reasonably active mutant which would allow us to identify the difference
between the N and C-terminal sites in the protein (Table 4.1). W132, although not
binding the substrate or the active site metal directly, was first investigated as a
simple means to perturb one active site (N-terminus) while leaving the other site
non-affected (C-terminus). This would allow for the determination of the spectral
features for each active site, which is necessary to continue study of this enzyme.
A mechanistic role was not initially proposed for this residue, this experiment was
simply an attempt to separate the EPR signals eminating from each terminus.
The first exciting development was the apparent loss of Mn(II) signal, which was
replaced with Mn(III) character which is weakly visible in parallel mode (red trace).
Figure 4.6 shows X-band of WT compared to W132F, while Figure 4.2.2 shows the
expanded W132F spectra. The features of interest are at g=2 (field 3000-4000 G),
which is indicative of octahedral Mn2+, g=8 (field 1500-2000), which is indicative of
penta-coordinate Mn2+ or Mn3+, and g=10 (field 500-1000 G), which is indicative
of octahedral Mn3+. To ensure that the metal incorporation was sufficient in the
W132F sample, the strength of the EPR signal was confirmed at high-field [74] as


























































Figure 4.6. WT and W132F X-band EPR traces
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Figure 4.7. W132F X-band EPR traces and calculated fine structure parameters
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preparation of these protein samples). Further simulations of the parameters, as
well as calculations from first principles, concur that reasonable parameters (for Mn)
would produce these EPR spectra (Table 4.3).
Table 4.2.
W132F Steady-state Kinetic Data
Protein KM Kcat/KM/Mn Metal
WT 2±1 9000±100 Mn
W132F 50±5 700±100 Mn
Links to Computational and Structural Results
Although the revelation regarding the oxidation state of the W132F mutant was
extremely interesting and opened new avenues for the consideration of redox chemistry
in OxDc, this was not our initial intent with these experiments. In fact, the initial
intent was to find a mutant enzyme that alters the N-terminal but not C-terminal
EPR parameters. At the the time of this mutant’s design, two EPR fine structure
parameters, E and D had been solved for two different signals, site ”I” and site
”II”. We also report a value of E/D as this is a less sensitive and thus more robust
value. These values were simulations generated from EPR spectra taken of the WT
enzyme. The same EPR experiments and subsequent simulations were completed on
the W132F enzyme variant. These site-specific values were possible only due to the
improvement in the preparation of the enzyme (as mentioned in the Introduction and
detailed in the Methodology sections respectively). Site ”I” shifts as a function of the
W132F mutation, whereas site ”II” does not shift. This suggests that site ”I” is the
N-terminus and that site ”II” is the C-terminus. These site-specific values could be
confirmed to be belonging to the site as suggested by the W132F mutant by optimized
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DFT/MM calculations. The calculated vs. experimental values, which confirm the
assignment of site ”I” to the N-terminus are found in Table 4.3.
Table 4.3.
Experimental and Calculated Fine Structure Parameters for OxDc
Protein source site D(MHz) E/D
WT experimental ”I” -1350 0.15
WT DFT/MM-optimized N-terminal -1170 0.11
WT experimental ”II” 10430 0.20
WT DFT/MM-optimized C-terminal 4110 0.22
W132F experimental ”I” -1950 0.21
W132F DFT/MM optimized N-terminal -2100 0.23
W132F experimental ”II” 10430 0.20
W132F DFT/MM optimized C-terminal 4110 0.22
4.2.3 Q282W and W132Q
When comparing the N-terminal site to the C-terminal site, W132 is obviouly a
trytophan that exists in the N-terminus and not in the C-terminus. What is then in a
similar place in the C-terminus? The C-terminus has a residue Q282 in a synonymous
location. We have previously seen the effect of changing W132 to Phenylalanine.
This change had electronic consequences for the enzyme which affected KM but not
kcat. What then would be electronic, and therefore kinetic, consequences of making
the C-terminus look like the N-terminus? Effectively, what are the consequences of
substituting Q282 for Q282W. This protein would have tryptophans in the second
shell of both metal-binding site. In fact the effects are significant. Q282W is more
active than WT, although it appears to lack the ability to bind Mn as efficiently.
Instead some amount of Mg is often found in these samples. Mg is an excellent
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Figure 4.8. High-field, High-Frequency EPR of the W132F variant
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Figure 4.9. N- and C-terminal Mn site first and second shell residues.
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structural substitute for Mn, as evidenced by studies using Mn in place of Mg for
Mg-catalyzed reactions with polyphosphate grops, or Mn in place of Mg in DNA
structure. However, there is nothing catalytic about Mg that portends that it can
in fact do redox chemistry. In fact, it is shown through very recent MCD and EPR
experiments, that there is more Mn3+ in Q282W than in W132F (which has some
Mn3+) or than WT (which appears to have no Mn3+). [75, 76]
Table 4.4.
Tryptophan Steady-state Kinetic Data
Protein KM Kcat/KM/Mn Metal
WT 2±1 9000±100 Mn
W132F 50±5 700±100 Mn
Q282W 3±1 15000±400 Mn,Mg
W132Q n/a n/a Mn
Fluoro-Trp mutants
Fluorine substitution is a strategy for altering the properties of small molecules
and proteins in biological systems. These pertubations can be used to identify the
role of the original non-fluorinated molecule (or, in the case of proteins, natural
amino acid). Fluorine is a fascinating substitution for hydrogen on amino acids
because it is small like hydrogen, but very polarizable. Fluorinated amino acids
can be globally substituted for a given amino acid (in this case tryptophan) as a way
to probe the role of tryptophan in the protein. Specifically, in Oxalate Decarboxylase,
we are interested to see if substitution of tryptophan with 5-fluorotrytophan has a
minimal effect (as would be suggested if tryptophan residues were merely electrostatic
contributors). If the effect of tryptophan substitution is very significant then this
suggests that the role of the tryptophan residues is more complex than a simple
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Figure 4.10. 5-fluorotryptophan
electrostatic contribution to the protein as a whole. In fact, the 5-fluoro-tryptophan
substitution made a substantial effect on the protein as a whole, with a 20x reduction
in the kcat/KM compared to WT. Perhaps more interestingly, the Fluorinated W132F
protein, which has six trytophans total compared to seven, is overall just as active (if
not more active) than the fluorinated version of the WT protein. Unfortunately these
fluorinated proteins suffer from low solubility and are not fit for EPR experiments
which require quite high concentrations. Experiments aimed at producing whole
protein mass spectrometry data for these fluorinated OxDcs as well as 19Fluorine-
NMR experiments have all failed due to the size of the protein complex. However,
the inclusion of the fluorine was confirmed through tryptic and chymotryptic digest
(Figure 4.11), followed by Mass Spectrometry.
Table 4.5.
Tryptophan Steady-state Kinetic Data
Protein KM Kcat/KM/Mn Metal
WT 2±1 9000±100 Mn
W132F 50±5 700±100 Mn
5-Fluoro-Trp 50±10 530±10 Mn
5-Fluoro-Trp-W132F 12±1 900±10 Mn
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Figure 4.11. Chymotrypsin Digest Coverage
Table 4.5 indicates that fluorinating all tryptophans makes the enzyme kineti-
cally very similar to W132F. No further harm to the kinetic parameters is seen when
a W132F protein is fluorinated, which suggests that residue W132 is actually cat-
alytically very important. This does not render the other tryptophan residues less
important, but further investigation, perhaps through site-directed substitution of
these fluorinated residues, is required. Sample MS coverage data, confirming that
visible tryptophan residues are indeed fluorinated, is shown in Figure 4.11.
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Figure 4.12. Current literature Mechanism for Oxalate Decarboxylase
4.2.4 How does Oxalate Bind to Manganese?
The current literature mechanism [68] is found in Figure 4.12, with discrepan-
cies between the current mechanism and current experiments highlighted in red.
I propose that the Mn cofactor is indeed undergoing reduction during the reaction.
Strong evidence for this proposal is supported by the dependence of the OxDc enzyme
on the Mn cofactor alone. Iron, Cobalt and copper, although able to incorporated
into the active site, do not support activity. This point suggests that the electronic
properties of Mn (and not simply the geometry or identity of the ligands) support
catalysis specifically. Previous reaction mechanism strategies include both a bifur-
cated [65] mechanism and a formyl radical anion mechanism [68]. In the former case,
both Mn(III) and Mn(II) species are considered necessary for the reaction, and this
appears to be evidenced through our recent EPR studies [74]. The coordination of
oxalate to Mn in this model is suspect. There is certainly no evidence (both experi-
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Figure 4.13. Novel Oxalate Decarboxylase Structures
94
mental and theoretical) to support a mechanism where no oxidation-reduction of the
Mn takes place. Several possible intermediates are proposed in Figure 4.13, which are
supported by current and historical OxDc data. This mode of binding differs signifi-
cantly from the previously suggested modes in several ways. The most imporatant of
which are that there is (1) no evidence for O2 binding to Mn, and thus this feature is
excluded (2) there is evidence of both Mn2+ and Mn3+ species according to EPR and
CD spectroscopy and (3) preliminary O17 oxalate EPR studies suggest that oxalate
must be bound bidentate in the active site. [76]
Mn oxidation state prior to binding oxalate
This mechanism depicts mono-protonated oxalate bound to a Mn(III) species.
Argument can be made about the Mn oxidation before binding to oxalate, and in
this occasion theory and experiment are not necessarily aligned. Experiment would
suggest that Mn(II) is the species before binding oxalate, but this may be because this
is the incorporated oxidation state (incorporating Mn(III) directly through a soluble
inorganic salt is not possible).
Mn binds oxalate
In either case, upon binding oxalate, Mn3+ is binding oxalate bidendate. I have
drawn formally the binding to be through different ends of the carboxyl moiety.
This is somewhat a formality, but draws attention to a particular point - that is the
protonation state of the oxalate group. It is known that oxalate binds monprotonated
to OxDc based on the optimal pH of the reaction (pH 4.2). At higher pHs, most
molecules of oxalate are symmetric and due to resonance in the carboxyl moiety there
is no difference in the way that oxalate is made to bind, as long as it is bidentate. If it
binds in a monoprotonated form, then the molecule is certainly no longer symmetric.
One could argue that a deprotonation step occurs immediatly before binding, but I am
excluding this possibility because kinetically this is a much more challenging scenario
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to consider. So, as oxalate binds to the Mn in a bidentate fashion, it does so across
the carbon-carbon bond, as is the classical mode of binding for oxalate in inorganic
Mn complexes. This mode of binding has been shown to elongate the carbon-carbon
bond in oxalate (already a long bond) slightly, which prepares the molecule for carbon-
carbon bond cleavage. The molecule binds such that one carboxyl group, which is
truly symmetric occupies one coordination site (and the formalism used here could
be altered, because again, this group is symmetric). The other coordination site
is occupied by the carboxylic acid moiety which is not symmetric. This binding
promotes an increase in positive charge on the Oxygen which in turn makes the
hydroxyl hydrogen a slightly better leaving group.
Formyl Radical Anion
A proton transfer adds more negative charge onto oxalate, which in turn propagate
a reaction which cleaves the carbon-carbon bond and creates a radical anion species
which has been spectroscopically identified. [68] (This spectroscopically identified
radical anion species is definitely from the Oxalate molecule, as shown through kinetic
isotope effect experiments with 13C substitutions in Oxalate. [66, 69]) An additional
proton transfer creates formate, the product, and creates two active sites on Mn which
are ready to coordinate oxalate again.
4.2.5 EPR of other OxDc mutants
Although the concentration of other OxDc mutants is not high enough at this
time to get definitive E and E/D fine structure parameter values, it is clear that the
fine structure of other mutants, such as W132Y, differs from that of W132F and WT.
Despite concentration problems with the less-soluble mutants, one can still obtain
spectra such as found in Figure 4.14.
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EPR studies can provide information regarding the unpaired electrons of high-spin
Manganese species (in both II and III oxidation states). In this approach, we search
wide field ranges, including very high field, as well as multiple frequencies and both
available modes of EPR pulse application in order to determine not only hyperfine
but also fine structure of the Manganese ions found in Oxalate Decarboxylase. In
order to introduce the specific forms of EPR that were implemented in this project,
a brief description of the different EPR methodologies is provided.
Introductory EPR Theory
An atom like Manganese has discrete energetic states, each with a corresponding
energy. EPR is simply a spectroscopic method to gain insight into the electronic
structure of Mn by probing the differences in these energy states. A fundamental
relationship (4.2) reflects the absorbed electromagnetic radiation E as a function of
Planck’s constant h and the frequency of radiation v.
hv = ∆E (4.2)
There are two more fundamental equations necessary to the study of EPR, which
introduce the concept of magnetic moment (µ), the external magnetic field (B) and
electron spin (S) (which are intentionally bold as this is a vector quantity). Ad-
ditionally, β is the Bohr magneton and g is the g-factor, otherwise known as the
spectroscopic splitting factor:
µ = −gβS (4.3)
E = −µ ·B (4.4)
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Through a series of derivations between these three fundamental equations, it
is clear that the change in energy experienced by an electron when exposed to an
external magnetic field is:
E = sgβB (4.5)
Because there are five unpaired electrons in Mn2+ and four unpaired electrons
in Mn3+ which experience cubic symmetry, there is an additional phenomenon called
zero-field splitting which has been discussed in detail in the introductio to this chapter.
This is due to interelectronic interactions, especially in ligand fields of low symmetry
or with high-distortion. Otherwise, the electrons are not in identical environments
before distortion by a magnetic field, and therefore have inherent degeneracy which
only exacerbates energy differences at field. The zero-field splitting hamiltonian,











It is difficult to interpret a physical meaning for D and E, but D can be understood
loosely as an axial distortion (for example, D would have magnitude if the axial bonds
in the Mn six-coordinate atom are longer or shorter than the planar bonds).
Finally, the six-shouldered splitting that is charateristic for Mn is due to the
nuclear moment (I=5
2
) which is consistent regardless of oxidation state, and therefore
should not change regardless of the direction of application of the magnetic field
(perpendicular or parallel mode) or of the dominant Mn based ion in solution.
4.3.2 Protein Production and Concentration
The gene encoding the W132F OxDc variant was produced using overlap extension
methodology using the following primer shown in Table 4.6.
Briefly, polymerase chain reactions (PCRs) were conducted in solutions containing
40 L H2O, 5L of PfuTurbo AD 10x buffer, 50 ng of template OxDC in pET32a, 0.25
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Table 4.6.
Example Sequencing and PCR Primers
Primer Sequence
WT (OxDc) Forward 5’-GGAGGAAACATCATATGAAAAAACAA-3’









mM dNTP mixture, 0.2 µM of forward primer, 0.2 µM of reverse primer, 1 µL of
PfuTurbo AD enzyme (50 µL total volume). The first set of PCRs were run for four
minutes at 95 ◦C followed by 30 cycles of denaturing at 95 ◦C for 30 s, annealing at 55
◦C for 1 min, and extension at 72 ◦C for 7 min. After a final extension phase at 72 ◦C
for 10 min, the solution was cooled to 4 ◦C. A second set of PCRs to stitch together
PCR products from the first round were then performed using solutions containing 40
µL H2O, 5 µL PfuTurbo AD 10x buffer, 1 µL of each of the first round PCR mixtures,
0.2 mM dNTP mixture, 0.2 µM of OxDC forward NdeI primer, 0.2 µM OxDC XhoI
reverse primer, and 1 µL PfuTurbo AD enzyme (50 L total volume). After following
an identical set of denaturing, annealing and extension cycles to those used in the first
round of PCRs, DNA was purified using a Wizard kit (Promega). The purified DNA
was cut at 37 ◦C for 1-2 hours using the XhoI and NdeI restriction enzymes (New
England Biolabs) and ligated into pET32a (Novagen), which had been cut previously
with NdeI and XhoI and treated with calf intestinal alkaline phosphatase (CIP).
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Ligation with T4 DNA ligase (New England Biolabs) was performed at 16◦ C for 16
hours. JM109 cells were transformed with the ligation mixture (1-5 µL), plated on
Luria broth with 0.1 mg/mL ampicillin and grown overnight at 37 ◦C. The resulting
colonies were grown overnight at 37 ◦C in LBA (50 mL) and plasmids purified using
a Wizard kit (Promega). DNA sequencing was then performed to ensure that the
correct mutation had been introduced into the gene (Interdisciplinary Center for
Biotechnology Research at the University of Florida).
Protein was produced as previously described [69], with some modifications. First,
it was very important to take only top-quality protein from the Ni2+ purification col-
umn. Therefore, only small amounts of protein were retrieved per liter, but this
protein was significantly more soluble than if the entire elution pool was collected.
This protein is extremely sensitive to high imidazole concentrations, which is not
unexpected from a protein whose primary ligation to it’s cofactor is through histi-
dine residues. It was very important to quickly and completely remove all imidazole
through a graduated buffer dialysis procedure. It was also important to maintain
the pH of the protein to much higher than pH 6.1, which is the calculated pI of the
protein. Concentration using standard procedures is effective, assuming that these
steps have been followed to ensure high quality hexameric protein with no imidazole
in solution.
4.3.3 Oxalate Decarboxylase Coupled Assay
The necessary stock solutions that are required to complete the OxDc coupled
assay are found in Table 4.7. An example worksheet is provided as Figure 4.15.
Each tube for assay includes the solutions as indicated in Table 4.8. After mixing
each assay solution, initiate by adding 1 U of OxDc purified enzyme. Then quench
each reaction within a known period of time (20 s for WT enzyme, more time for
slower mutant enzymes). Then mix, each quenched solution with 945 µL of the FDH
assay mixture, found in Table 4.9. Incubate this mixture overnight and then measure
101
Table 4.7.
FDH Assay Stock Solutions
Solution Concentration





Triton X−100 10% v./v.
Oxalate, pH 4.2 200 mM




FDH Assay Reaction Solutions
Solution Volume
200 mM Acetate, pH 4.2 25 µL
50 mM o-PDA 1 µL
10% Triton X−100 2 µL
Oxalate, pH 4.2 50 µL
water to 50 µL total
the UV absorbance at A340. Compare values to the standard curve to calculate
formate concentration produced in each sample. Assume that one formate molecule
is made from each molecule of oxalate. Use these oxalate concentrations consumed
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as a function of time to generate Michaelis-Menten kinetic parameters. An example
worksheet is found as Figure 4.16.
Table 4.9.
FDH Assay Coupling Solution
Solution Concentration
1.0 M KPi, pH 7.8 50 µL
15 mM NAD+ 100 µL
FDH 0.1 mg




Formate	  Standards: Prepare	  in	  small	  tubes
(uL) A B C D E F G
100	  mM	  formate 0 1 2 4 6 8 10
water 10 9 8 6 4 2 0
Final	  [formate]	  (mM) 0 1 2 4 6 8 10
Add	  100	  uL	  of	  this	  mix	  to	  each	  tube:
Solution [Stock] V	  1	  rxn	  (uL) [Rxn] V	  mix	  (uL) 8
Acetate	  (pH	  4.2) 200	  mM 25 50	  mM 200 ^-­‐-­‐factor
o-­‐PDA 50	  mM 1 0.5	  mM 8
triton-­‐X 10% 2 0.20% 16 Now	  have	  10	  tubes	  with	  
oxalate	  (ph	  4.2) 200	  mM 25 50	  mM 200 110	  uL	  each.	  	  Put	  aside.
water -­‐-­‐-­‐ 37 -­‐-­‐-­‐ 296
NaOH 1	  M 10 0.1	  mM 80
Total	  Volumes	  (uL) 100 800
Reaction:
Prepare	  and	  add	  50	  uL	  of	  this	  mix	  to	  small	  tubes	  (one	  per	  sample)
Solution [Stock] V	  1	  rxn	  (uL) [Rxn] V	  master 152
Acetate	  (pH	  4.2) 200	  mM 25 50	  mM 3800 ^-­‐-­‐factor
o-­‐PDA 50	  mM 1 0.5	  mM 152
triton-­‐X 10% 2 0.20% 304
protein 1 152
water -­‐-­‐-­‐ 21 -­‐-­‐-­‐ 3192
Total	  Volumes	  (uL) 50 7600
Initiate	  with	  oxalate	  and	  after	  1	  minute,	  quench	  with	  NaOH	  (Add	  10	  uL	  of	  1.0	  M	  to	  each	  reaction)
Oxalate	  mixes	  -­‐	  need	  50	  uL	  total	  volume/reaction
[oxalate]	  aliquots Oxalate	  Stock Oxalate	  (uL) H20	  (uL) Oxalate	  (uL) H20	  (uL) total	  volume [Oxalate]	  Final	  mM
0 200 0 50 0 750 750 0
2 200 0.5 49.5 7.5 742.5 750 1
4 200 1 49 15 735 750 2
10 200 2.5 47.5 37.5 712.5 750 5
20 200 5 45 75 675 750 10
50 200 12.5 37.5 187.5 562.5 750 25
100 200 25 25 375 375 750 50
200 200 50 0 750 0 750 100
1000 1000 50 0 750 0 750 500
COUPLED	  ASSAY
Prepare	  in	  Falcon	  tube:
Solution [Stock] V	  1	  rxn	  (uL) [Rxn] V	  master	  (uL) 160
Kpi	  (pH	  7.8) 1	  M 50 50	  mM 8000 ^-­‐-­‐factor
NAD	  + 15	  mM 100 0.5	  mM 16000
FDH -­‐-­‐-­‐ 2 0.20% 320
water -­‐-­‐-­‐ 848 50	  mM 135680
Total	  Volumes	  (uL) 1000 160000
Add	  945	  uL	  of	  this	  mix	  to	  large	  test	  tubes,	  one	  corresponding	  to	  every	  formate	  standard	  and
one	  for	  every	  sample	  and	  blank.	  	  Add	  55	  uL	  of	  the	  corresponding	  "small"	  tube	  to	  each	  and
incubate	  overnight	  at	  37C.	  	  Read	  Absorbance	  at	  340	  nm	  (UV/Vis)
make	  1 make	  15	  (3	  each	  variant)
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4.16. Michaelis-Menten Kinetics Worksheet
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ABSTRACT: Oxalate decarboxylase (OxDC) catalyzes the Mn-dependent
conversion of the oxalate monoanion into CO2 and formate. EPR-based
strategies for investigating the catalytic mechanism of decarboxylation are
complicated by the difficulty of assigning the signals associated with the two
Mn(II) centers located in the N- and C-terminal cupin domains of the enzyme.
We now report a mutational strategy that has established the assignment of EPR
fine structure parameters to each of these Mn(II) centers at pH 8.5. These
experimental findings are also used to assess the performance of a multistep
strategy for calculating the zero-field splitting parameters of protein-bound
Mn(II) ions. Despite the known sensitivity of calculated D and E values to the
computational approach, we demonstrate that good estimates of these parameters can be obtained using cluster models taken
from carefully optimized DFT/MM structures. Overall, our results provide new insights into the strengths and limitations of
theoretical methods for understanding electronic properties of protein-bound Mn(II) ions, thereby setting the stage for future
EPR studies on the electronic properties of the Mn(II) centers in OxDC and site-specific variants.
■ INTRODUCTION
Oxalate decarboxylase (OxDC) catalyzes the Mn-dependent
conversion of oxalate monoanion into CO2 and formate.
1
Although the enzyme appears to be found in many fungi and
some bacteria,2 its biological function remains poorly under-
stood. It has been shown, however, that OxDC is a constituent
protein of the spore coat formed by Bacillus subtilis.3 The
enzyme may also find utility in a number of biotechnological
applications.4 Details of the mechanism by which OxDC
mediates cleavage of the chemically unreactive C−C bond in
oxalate5 remain to be clearly delineated. Heavy-atom isotope
effect (IE) measurements6 and recent spin-trapping experi-
ments7 are consistent with the hypothesis that reaction
proceeds via heterolytic breakdown of a manganese-bound
oxalate radical anion.8 In principle, the presence of Mn(II) in
OxDC offers the opportunity to use EPR methods to explore
the mechanistic role of the metal ion in catalysis.9 The situation
is complicated, however, by the fact that the enzyme is
composed of two cupin domains, each of which contains a
Mn(II) ion in a similar coordination environment (Figure 1).10
As a result, even the high-field EPR spectra of the wild-type
enzyme in buffer are complicated, and the effects of substrate
binding and/or catalysis at a specific metal center are difficult to
observe. It is therefore not surprising that two prior
experimental studies have yielded conflicting assignments for
the observed fine structure parameters of the two Mn(II)
centers.12
In principle, the application of modern theoretical methods
to obtain estimates of the fine structure parameters D and E
associated with each of the two Mn(II) centers in OxDC
represents a means of resolving the discrepancy in assignments
of the previous EPR studies. In practice, however, any accurate
computation of fine structure parameters from first principles
represents a significant challenge for modern quantum
mechanical methods. This is especially true for high-spin d5
systems where the balance between the direct electron−
electron magnetic dipole spin−spin (SS) interaction involving
unpaired electrons and a second order term, arising from the
spin−orbit coupling (SOC) of electronically excited states into
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the ground state, gives rise to very small D values ranging from
nearly 0 to 1.5 cm−1 (corresponding to interaction energies on
the order of 0.004 kcal mol−1). Estimates of fine structure
parameters obtained using theoretical methods are therefore
the difference between large contributions that have the same
order of magnitude and opposing signs. Thus, even minor
errors in calculating either of the SS or SOC contributions can
significantly affect the accuracy of the final results.13 Efforts to
employ density functional theory (DFT) for the accurate
prediction of fine structure parameters are also complicated by
the delicate balance between exchange and correlation
contributions. Be that as it may, any demonstration that
theoretical calculations are capable of yielding even qualitative
insights into zero-field splittings would have wide application in
the study of Mn-dependent enzymes and likely facilitate the
interpretation of EPR spectra for multicenter systems, such as
OxDC.9 To date, however, only one study has been published
in which an integrated experimental/computational strategy
was used to assign the fine structure parameters associated with
Mn(II) ions bound to enolase.14
We now report a mutational strategy that has allowed us to
establish the assignment of EPR fine structure parameters to
each of the Mn(II) centers in wild-type OxDC, at least at high
solution pH. This work has also provided an opportunity to
assess the performance of a combined DFT and DFT/MM
computational strategy for calculating the zero-field splitting
(zfs) parameters of the protein-bound Mn(II) ions in OxDC.
Despite the known sensitivity of calculated D and E values to
the computational approach,15 we demonstrate that good
estimates of these parameters can be obtained using cluster
models taken from carefully optimized DFT/MM structures.
Overall, our findings not only confirm the assignments of
Tabares et al.12b but also provide new insights into the
strengths and limitations of theoretical methods for under-
standing electronic properties of protein-bound Mn(II) ions.
This work also sets the stage for future EPR studies on the
electronic properties of the Mn(II) centers in OxDC and site-
specific variants.
■ RESULTS AND DISCUSSION
High-Field (326.4 GHz) EPR Spectroscopy of Wild-
Type OxDC. Mn(II) is a d5 ion with a total spin quantum
number of S = 5/2. The transition between the mS = −5/2 and
mS = −3/2 electron spin manifolds is emphasized at
temperatures below 4 K because of a large population
difference according to Boltzmann statistics.16 Spectroscopi-
cally, this transition extends over a field range of 6(D + E)/gμB,
whereas that of the next higher energy transition between mS =
−3/2 and mS = −1/2, typically observed at temperatures above
5 K, is only 3(D + E)/gμB.
12b This is also true for the central
transition between mS = −1/2 and mS = +1/2, although
because these transitions are not directly affected by the fine
structure to first order they are typically very sharp and intense.
Importantly, frozen solution spectra observed at very low
temperatures, at or below 4 K, which feature the mS = −5/2
and mS = −3/2 transitions, allow the direct determination of
not only D and E values but also the sign of D.12b Hence, the
largest deviation of the powder spectrum from the center
happens at low field with the main turning point at −4|D|/gμB
(measured from the center of the spectrum) for negative D
values, whereas the highest field component appears at (2|D| +
6|E|)/gμB (Figure S1 in Supporting Information). The situation
is reversed if D has a positive sign. In the event that the
rhombic component, E, has an appreciable magnitude, a
splitting is observed on the side with the smaller deviation from
the center, featuring signals at (2|D| + 6|E|)/gμB and (2|D| − 6|
E|)/gμB. The sign of E depends on how one defines the x- and
the y-axis of the fine structure tensor, and it can only be
determined using single-crystal EPR spectroscopy.16
In studies of OxDC and its site-specific variants, our strategy
of resolving the fine structure relies on observing the transitions
between higher mS states at the lowest possible temperature,
which is between 2.5 and 3 K for our helium flow cryostat.
These transitions are usually not very strong and require
enzyme concentrations on the order of 20 mg/mL or higher to
be reliably observed. We also routinely take EPR spectra at
intermediate temperature (40 K) to distinguish between species
exhibiting small and relatively large magnitudes of the fine
structure parameters D and E. The high-field EPR (326.4 GHz)
spectrum of wild-type (WT) OxDC at pH 8.5 in frozen
solution (3 K) clearly showed transitions associated with higher
mS states (Figure 2), enabling us to determine the fine structure
values directly for at least one of the two Mn(II) species
present in the enzyme. This pH was chosen because the X-ray
crystal structure of WT OxDC, which was used in DFT and
DFT/MM calculations, was obtained by crystallization at pH
8.5. We also note that observation of these weak transitions
required the use of high enzyme concentrations (27 mg/mL),
which could be achieved by modification of published
purification protocols.3,5,7 The intensity of the central |+1/2⟩
↔ |−1/2⟩ sextet centered at 11658 mT was greatly reduced
due to Boltzmann population favoring the transition from the
lowest level within the electron spin manifolds, |−5/2⟩↔ |−3/
2⟩. On its low-field side, a broad peak was visible, centered at
around 11450 mT, and on the high-field side, there was a
negative signal at 11760 mT. A poorly resolved shoulder was
observed above 11800 mT instead of the expected rhombic
splitting, and because a fully axial fine structure tensor would
yield a much narrower peak at high fields, this implied that the
Figure 1. Representations of the Mn(II) binding sites in the N-
terminal (right) and C-terminal (left) domains of Bacillus subtilis
oxalate decarboxylase (1UW8).10a The location of the two Mn(II)
centers in the monomer are indicated by the solid spheres in the
ribbon drawing (top). Residue numbering is for the Bacillus subtilis
enzyme. Color scheme: C, cyan; N, blue; O, red; Mn, purple. Metal-
bound water molecules are shown as red spheres. The figure was
rendered using VMD.11
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fine structure parameter, E, had a broad distribution spanning
essentially the whole range from zero to the maximum possible
value of |D|/3. By using a broad Gaussian distribution of E
centered around 200 MHz with a half-width of 800 MHz,
however, we were able to obtain a reasonable fit of the
experimental spectrum (Figure 2). On the other hand, this
approach was unable to recover the high-field shoulder present
in the spectrum, implying that our experimental E/D ratios
(Table 1) have large errors associated with them, thereby
making it difficult to draw hard conclusions from these values.
The spectrum at 40 K primarily showed the |−3/2⟩ ↔ |−1/
2⟩ transitions on the low- and high-field side of a much stronger
set of central |+1/2⟩ ↔ |−1/2⟩ sextet lines relative to those
seen at 3 K (Figure 2). These transitions were now located
closer to the spectral center, and the |−5/2⟩ ↔ |−3/2⟩
transitions were barely visible above the noise. Interestingly,
there were three relatively sharp transitions visible on the low-
field side of the spectrum together with a broader feature on the
high-field side as one would expect from a pentacoordinate
species with |D| of approximately 10 GHz. The appearance of
overlapping spectra with differing zero-field splittings is
consistent with the fact that OxDC contains two Mn binding
sites.12 Simulations of the 40 K high-field EPR spectrum using
the site I magnetic parameters extracted from the spectrum at 3
K together with a second species (site II) having very large fine
structure (∼10 GHz) gave a satisfactory global fit (Figure 2)
and yielded similar values for the fine structure parameters D
and E (Table 1) to those reported previously.9b Site I has the
smallest |D| value and carries about 68% of the spectral weight.
Unfortunately, the transitions associated with the second
Mn(II) (site II) were not of sufficient intensity to allow direct
experimental observation. Instead, we had to rely on the
second-order effect of the fine structure on the central mS =
−1/2 to mS = +1/2 transitions, manifesting itself through
broadenings and spectral splittings, which turn the sextet lines
into a group of sharp lines at low field complemented by a
broad Pake pattern on the high-field side (Figure S2 in
Supporting Information).17 Given that these are second-order
effects on the +1/2 ↔ −1/2 transitions, no information
concerning the sign of D could be obtained from our
simulation. Values for the g-factor and hyperfine coupling
constant A with the 55Mn nucleus were also obtained for the
two Mn(II) sites in the enzyme (Table S1 in Supporting
Information). Both of these sites are similar to ones reported by
Tabares and co-workers (Table 1),12b with site II most
probably corresponding to a pentacoordinate Mn(II) ion
observed in the C-terminal domain of the enzyme by X-ray
crystallography (Figure 1).10a Hence, site I is likely associated
with a hexacoordinate Mn(II) bound within the N-terminal
domain of the enzyme.
Preparation and Kinetic Characterization of the
W132F OxDC Variant. In order to confirm these assignments,
Figure 2. High-field (326.4 GHz) EPR spectra of WT OxDC taken at
3 K (black) and 40 K (blue) together with spectral simulations. Note
that the central part of the spectrum at 40 K together with the
corresponding spectral simulation of site I is removed for clarity. The
enzyme (27 mg/mL) was dissolved in 50 mM Tris buffer containing
500 mM NaCl, pH 8.5. Lines from spectral simulations correspond to
a single Mn(II) species (site I) with small zfs at 3 K (red) and 40 K
(green) and a single Mn(II) species (site II) with very large zfs at 40 K
(cyan). The sum of site I and site II simulations at 40 K is also shown
(magenta). We note that site II does not contribute significantly to the
spectral range visible. Unedited spectra and full sets of simulation
parameters are provided elsewhere (Figures S2−S4 in Supporting
Information).
Table 1. Experimental and Calculated Fine Structure Parameters, D and E, of the N-Terminal and C-Terminal Mn(II) Binding
Sites in WT OxDC and the W132F OxDC Variant
site I site II
enzyme (active site) type (pH) D (MHz) E/D |D| (MHz) E/D
WT OxDC experimental (8.5) −1350 0.15a 10430 0.20a
WT OxDC (Tabares et al.)12b Experimental (8.8) −1110 0.27 10730 0.16
WT OxDC (N-terminal) DFT/MM-optimized −1170 0.11 g
WT OxDC (C-terminal)b DFT/MM-optimized 4110h 0.22
WT OxDC (C-terminal)c DFT/MM-optimized 4560h 0.14
WT OxDC (C-terminal)d DFT/MM-optimized 7130h 0.13
W132F experimental (8.5) −1950 0.21a 10430 0.20
W132F (N-terminal)e DFT/MM-optimized −2100 0.23
W132F (N-terminal)f DFT/MM-optimized −1350 0.10
aThe error for E/D values obtained in the present study is very large due to the broad distribution of E values that had to be assumed in the
simulations. These values are obtained from the center of a broad Gaussian distribution of E (see text for more details). bCluster model containing
water as the fifth ligand (Figure 7b). cCluster model containing hydroxide as the fifth ligand (Figure 7c). dCluster model containing hydroxide as the
fifth ligand with a hydrogen bond to a solvent water (Figure 7d). eInitial structure for QM/MM optimization based on the X-ray crystal structure of
Co(II)-containing W132F OxDC variant. fInitial structure for QM/MM optimization from in silico modification of the X-ray crystal structure of WT
OxDC (1UW8). gNot applicable. hIn the text, we report either the positive or the negative D value as obtained by calculation. In this table, however,
we give only absolute values for D in the case of the C-terminal site because the sign of this parameter could not be experimentally determined.
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we decided to prepare a site-specific OxDC variant in which
only the zfs parameters of the N-terminal Mn(II) center would
be perturbed, thereby leading to a shift in the D and E values
associated with only one site. An analysis of the second sphere
interactions revealed a hydrogen bonding interaction between
the side chains of a conserved tryptophan (Trp-132) and the
glutamate (Glu-101) coordinating Mn(II) in the N-terminal
domain (Figure 3). We anticipated that removing this hydrogen
bond would perturb the Mn(II)/Glu-101 interaction, thereby
affecting the zfs parameters, and so the W132F OxDC variant,
in which Trp-132 is replaced by phenylalanine, was expressed
and purified following our standard procedures.6 Metal analysis
showed that the recombinant enzyme contained 1.6 Mn/
monomer. Steady-state kinetic analysis gave values of 63 s−1
and 50 mM for kcat and Km, respectively (Figure S5 in
Supporting Information), and so the W132F OxDC variant
exhibited a 10-fold lower catalytic efficiency (kcat/Km) than WT
enzyme after normalizing for Mn(II) incorporation. However,
the observations that (i) kcat was essentially unaffected by the
site-specific mutation and (ii) Mn(II) incorporation was very
similar in WT OxDC and the W132F OxDC variant supported
the idea that the tertiary structure was not significantly affected
by removal of the hydrogen bonding interaction.
X-ray Crystallography of the Co-Substituted W132F
OxDC Variant. In order to ensure that there was indeed
minimal impact on Mn(II) coordination and local protein
structure as a result of replacing Trp-132 by phenylalanine, we
sought to obtain an X-ray crystal structure of this OxDC
variant. All efforts to grow diffraction quality crystals of the
Mn(II)-substituted form of the W132F OxDC variant proved
unsuccessful. We were able, however, to express and purify the
Co(II)-containing form of the mutant enzyme using conditions
that had been developed in prior investigations into OxDC
metal selectivity,8a and this material gave crystals that were
suitable for structure determination. The X-ray crystal structure
of Co-substituted W132F OxDC was solved using phases
calculated by molecular replacement and refined to a resolution
of 2.1 Å. The overall protein fold of the Co-containing W132F
variant did not differ significantly from WT enzyme, and the
two structures superimposed with an rmsd of only 0.26 Å.
More importantly, perhaps, the phenyl ring in the OxDC
W132F variant was positioned in an identical orientation to the
indole side chain of Trp-132 within the N-terminal Mn(II)
binding site (Figure 4). Comparison of the metal−ligand bond
distances in the Co-substituted form of the W132F OxDC
variant and the Mn-containing WT enzyme also showed that
they do not vary significantly in light of a 0.23 Å coordinate
error for the W132F structure (Figure S6 in Supporting
Information). This similarity of Co(II) and Mn(II) metal−
ligand bond lengths in OxDC is consistent with data in the
Scripps Metalloprotein Database.18 For example, the average
bond lengths for protein residues to Mn(II) ranges from 1.5 to
2.9 Å with an average value of 2.20 Å. Co(II)-containing
proteins have an average amino acid ligand bond length of 2.16
Å and range from 1.55 to 2.69 Å. Similarly, the bond distances
for water ligands bound to Mn(II) and Co(II) range from 1.05
to 3.09 Å (2.26 Å average) and 1.36−2.99 Å (2.26 Å average),
respectively. Hence, at least in terms of metal−ligand bond
distances and angles, Co(II) is a good mimic of Mn(II). As
importantly, and despite the fact that Co-containing WT OxDC
is catalytically inactive,8a the side chain carboxylate of the
functionally important residue Glu-162,19 which is located on a
mobile active site loop segment Ser161-Glu162-Asn163-Ser164
(Bacillus subtilis numbering),10,20 undergoes only a small shift
in position as a result of the site-specific mutation. On the other
hand, we noted that the ring of His-97 had become “flipped”
relative to its orientation in WT OxDC (Figure 5). Efforts to
refine the structure of the variant enzyme with His-97 oriented
in the same manner as observed in WT enzyme, however,
merely resulted in reorientation of the ring to the original
position in our initial structure for the W132F variant. The
correct positioning of the His-97 side chain was also verified by
Figure 3. Schematic representation of hydrogen bonding interactions
(dotted lines) involving residues in the Bacillus subtilis OxDC N-
terminal Mn(II) binding site when the active site loop adopts a
“closed” conformation.10a The Glu-101/Trp-132 hydrogen bond is
shown in red. Reproduced with permission from ref 10a. Copyright
2004 American Society for Biochemistry and Molecular Biology. Figure 4. Schematic representation of the structural changes in the N-
terminal (top) and C-terminal (bottom) metal centers resulting from
replacement of Trp-132 by phenylalanine. The figure was generated by
superimposing the X-ray crystal structures of WT OxDC (1UW8)
(purple) and the Co-containing W132F OxDC variant (green). The
figure was rendered using VMD.11
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a composite omit map (Figure S7 in Supporting Information).
Importantly, the structure of the Co-substituted enzyme
confirmed that replacement of Trp-132 by phenylalanine did
not perturb the structure of the C-terminal Mn(II) binding site
(Figure 4).
High-Field EPR (326.4 GHz) Spectroscopy of the
W132F OxDC Variant. Given the kinetic and structural
evidence that removal of the hydrogen bonding interaction
between Glu-101 and Trp-132 was likely only to perturb the N-
terminal Mn(II) center, we measured the high-field EPR (326.4
GHz) spectrum of the W132F OxDC variant at pH 8.5 (Figure
6). The W132F OxDC variant shows a broader spectrum of its
transitions between higher mS states when compared with the
WT enzyme. Hence, the low-field maximum now appeared at
11386 mT, and although the negative peak appeared to be
centered at 11780 mT (little shifted compared to WT enzyme),
it was broader and reached out to higher fields (Figure 6). As
perhaps expected from the negligible alterations to the structure
of the C-terminal Mn(II) binding site in the Co-substituted
W132F OxDC variant (Figure 4), the 40 K EPR spectrum
showed evidence for a pentacoordinated Mn(II) species
exhibiting the telltale sharp peaks at the low-field side and a
Pake pattern at the near high-field side of the spectrum. As in
our earlier studies of WT OxDC, we were able to simulate the
observed transitions by assuming that only two Mn sites were
present (Figure 6). Hence, assuming a single Mn(II) species
having a negative D value of −1950 MHz and a large Gaussian
distribution of E values centered around 400 MHz with a half-
width of 1200 MHz gave a reasonable simulation of the low-
field side of the spectrum even though the broad feature on the
high-field side could only be partially reproduced. An improved
simulation could be obtained using a much broader non-
Gaussian spectral distribution of D and E in which D and E
ranged between −1600 and −2100 MHz and between 100
MHz and the maximum value of |D|/3, respectively (Figure S10
in Supporting Information). Both simulations, however,
provide clear experimental evidence for a significant increase
in the magnitude of D for one of the Mn(II) sites in the W132F
OxDC variant when compared to WT enzyme. This
spectroscopic behavior is therefore consistent with the
hypothesis that removal of the Glu-101/Trp-132 hydrogen
bond would impact the electronic structure of the Mn(II) ion
bound in the N-terminal domain.
DFT and DFT/MM Calculations on WT OxDC. The
ability of DFT and wave-function-based methodologies (widely
and successfully used to model mononuclear inorganic
complexes21) to compute zfs values for a series of Mn(II)
transition metal complexes has been evaluated.15 Perhaps,
unsurprisingly, these studies revealed that the computed zfs
values are highly dependent on molecular geometry. The
availability of good structural and experimental zfs data for WT
OxDC offered the opportunity to examine whether QM/MM
methods for obtaining optimized active site geometries might
yield structures that could (at the very least) be used to
compute qualitatively correct estimates of the zfs parameters for
protein-bound Mn(II) ions. Thus, an initial structure for
performing QM/MM geometry optimizations was generated
from classical MD simulations of WT OxDC solvated in water
at physiological conditions. Although two X-ray structures have
been reported for the enzyme, we used the one containing a
pentacoordinate Mn(II) ion in the C-terminal domain (PDB
ID: 1UW8) to obtain the initial set of atomic coordinates for all
subsequent calculations on WT OxDC (Figure 1). After QM/
MM optimization of the metal centers in the initial enzyme, a
set of cluster models were defined in which only OH/H2O
molecules in the active site cavity and the side chains of all the
residues in the first coordination sphere around the metal were
included (Figure 7).
These models were then used in calculations of the zfs
parameters that employed the hybrid B3LYP22 functional in
conjunction with triple-ζ (def2-TZVP) valence basis sets.
Remarkably, excellent agreement was obtained in the prediction
of both D and E/D values when QM/MM-optimized
geometries were used to obtain the atomic coordinates for
these models, showing the importance of the surrounding
residues in modulating the geometric features of the OxDC
active sites (Table 1 and Table S2 in Supporting Information).
Figure 5. Superimposition of the Mn(II) N-terminal binding sites
observed in the X-ray crystal structures of WT OxDC (orange) and
the Co-containing W132F OxDC variant (green). Only the residues in
the first coordination sphere around the metal are depicted as sticks.
Figure rendered using VMD.11
Figure 6. High-field (326.4 GHz) EPR spectra of the Mn-containing
W132F OxDC variant taken at 3 K (black) and 40 K (blue) together
with spectral simulations. Note that the central part of the spectrum at
40 K together with the corresponding spectral simulation of site I is
removed for clarity. The enzyme (40 mg/mL) was dissolved in 50 mM
Tris buffer containing 500 mM NaCl, pH 8.5. Lines from spectral
simulations correspond to a single Mn(II) species (site I) with small
zfs at 3 K (red) and 40 K (blue) and a single Mn(II) species (site II)
with very large zfs at 40 K (cyan). The sum of site I and site II
simulations at 40 K is also shown (magenta). We note that site II does
not contribute significantly to the spectral range visible. Unedited
spectra and full sets of simulation parameters are provided elsewhere
(Figures S8−S10 in Supporting Information).
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For example, the D value of −1170 MHz computed for the N-
terminal Mn(II) cluster model (Figure 7a) was similar in both
sign and absolute magnitude to that observed for site I (D =
−1350 MHz, Table 1). Computing good estimates for the D
value associated with the C-terminal Mn(II) center required
more effort. For example, an initial calculation on a cluster in
which water was used as the fifth ligand (Figure 7b) gave a D
value of −4110 MHz from B3LYP/def2-TZVP calculations,
which is considerably smaller than the observed |D| value of
10430 MHz (Table 1). Closer examination of the X-ray crystal
structure, however, showed that the Mn−O distance in the C-
terminal Mn(II) site was only 2.15 Å, whereas both Mn−O
distances for the metal center in the N-terminal domain were
significantly longer (2.31 and 2.33 Å). This observation thereby
raised the possibility that the fifth ligand in the C-terminal site
was a hydroxide ion rather than water. As a result, and
especially given that the crystal structure (1UW8) had been
obtained at pH 8.5, we examined the effects of modeling the
fifth ligand as a hydroxide ion. We therefore reoptimized the
WT OxDC following the protocol previously outlined, except
that hydroxide was bound to the metal in the C-terminal
binding site, and created another cluster model of this Mn(II)
center (Figure 7c). B3LYP/def2-TZVP calculations using this
third model gave a computed D value of 4560 MHz, which was
a slight, albeit small, improvement. We noticed, however, that
additional water molecules entered the C-terminal Mn(II)
binding site during the initial set of classical MD simulations
used in equilibrating the system. One of these waters formed a
hydrogen bond to the Mn(II)-bound hydroxide ligand after
DFT/MM optimization. The B3LYP/def2-TZVP calculations
were therefore repeated for a new cluster model containing this
water molecule (Figure 7d), with the result that a D value of
−7130 MHz was obtained. This is in much better agreement
with the experimentally observed value for the site II Mn(II)
species. We also note that the calculated E/D ratio for site I was
similar to that obtained by analyzing the high-field EPR spectra,
although any comparison of theoretical and our experimental
E/D values is devalued by the broad distribution of E values
needed in the spectral simulations. Despite this complication,
our DFT-based computational strategy again supports the zfs
assignments of Tabares et al.12b
DFT and DFT/MM Calculations on the W132F OxDC
Variant Built from the X-ray Crystal Structure of the
Co(II)-Containing Enzyme. As an additional validation of our
strategy for obtaining accurate geometries for Mn(II) binding
sites in proteins that permit practically useful theoretical
estimates of their corresponding zfs values, we constructed an
optimized model of the Mn(II)-containing W132F OxDC
variant based on the 2.1 Å resolution X-ray crystal structure of
the Co(II)-substituted enzyme. After “replacing” the Co(II)
ions with Mn(II), our standard DFT/MM procedure was used
to optimize the resulting structure. As discussed above, the N-
terminal Mn(II) coordination environment in the initial
configuration exhibited some unexpected features, including
(i) rotation of the His-97 imidazole ring by about 180° relative
to its orientation in the X-ray crystal structure of WT OxDC,
and (ii) almost identical Mn−Nε (2.45 Å) and Mn−Cε (2.47
Å) distances for the interaction of the metal with His-97
(Figure 5).
In contrast, the final computational model of the Mn(II)-
containing W132F OxDC variant obtained using our standard
protocol (equilibration using classical MD simulation followed
by DFT/MM optimization) did not contain these unexpected
structural features (Figure 8). Thus, the His-97 imidazole ring
underwent a rotation of about 70° with respect to its
orientation in the initial structure, and the Mn−Nε (2.24 Å)
and Mn−Cε (3.21 Å) distances became appreciably different.
Most importantly, however, B3LYP/def2-TZVP calculations on
a cluster model of the N-terminal Mn(II) site gave a D value of
−2100 MHz in very good agreement with experiment (D =
−1950 MHz) (Table 1).
DFT and DFT/MM Calculations on the W132F OxDC
Variant Built from the X-ray Crystal Structure of WT
Figure 7. Cluster models taken from the DFT/MM-optimized
structure of WT OxDC that were used to calculate the zfs values of
the bound Mn(II) ions in the (a) N-terminal and (b−d) C-terminal
domains (see text for details). Color scheme: C, cyan; H, white; N,
blue; oxygen, red; Mn, tan.
Figure 8. Superimposition of the N-terminal Mn(II) binding sites
present in the X-ray crystal structure of the Co-containing W132F
OxDC variant (green) and the DFT/MM-optimized structure of the
Mn(II)-containing W132F OxDC variant (gray). Only the residues in
the first coordination sphere around the metal are depicted as sticks.
Figure rendered using VMD.11
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OxDC. We also assessed the ability of our computational
protocol to be employed in a predictive manner by calculating
the Mn(II) zfs values for the N-terminal metal center in a
model of the W132F OxDC variant prepared by in silico
mutation. Hence, the X-ray crystal structure of WT OxDC
(1UW8) was computationally modified so that Trp-132 was
replaced by a phenylalanine residue. The resulting model was
then equilibrated and optimized using our standard protocol to
give a final structure in which the hydrogen bond between the
Glu-101 side chain, and the closest Mn(II)-bound water
became slightly shorter as a consequence of removing the
interaction between Glu-101/Trp-132 (Table 2). Changes in
other metal−ligand bond distances were also observed together
with slight changes in the locations of the side chains of some
nearby residues. Once again, B3LYP/def2-TZVP calculations
were performed on a cluster model of the N-terminal Mn(II)
site corresponding to that used for calculations on WT OxDC
(Figure 7a). The computed D value of −1350 MHz (Table 1)
shows that this optimized model structure captures the
increased magnitude of D that is experimentally observed on
removal of the Glu-101/Trp-132 hydrogen bond. On the other
hand, the absolute value is smaller than that computed from a
model based on the X-ray crystal structure of the Co(II)-
containing W132F OxDC variant (Table 1). Given that
superimposition of the two cluster models used to compute
the zfs parameters for the N-terminal Mn(II) site in the W132F
OxDC variant showed all metal−ligand distances to be similar
in both structures, the difference in the calculated D values
likely arises from altered orientations of the imidazole rings of
His-97 and (to a smaller extent) His-95 (Figure 9). Taken
overall, these results suggest that the computational strategy
described in this paper yields reliable structural information
and, as a consequence, very good estimates of zfs values for
protein-bound Mn(II) centers. Importantly, our approach
opens the possibility of computing fine structure parameters
Table 2. Mn(II)−Ligand Internal Coordinates in the Cluster Models Used To Obtain the Computed Zero-Field Splitting Values
internal coordinatea WT OxDCb WT OxDCc WT OxDCd W132F (model 1)e W132F (model 2)f
Mn−O(Glu101)g 2.12 h 2.15 2.11
Mn−N(His95) 2.29 2.24 2.27
Mn−N(His97) 2.31 2.24 2.31
Mn−N(His140) 2.36 2.36 2.35
Mn−O(Wat1) 2.33 2.39 2.36
Mn−O(Wat2) 2.21 2.28 2.19
(Glu101)O−Mn−N(His95) 172.6 168.8 176.3
(Glu101)O−Mn−N(His97) 89.3 87.3 87.2
(Glu101)O−Mn−N(His140) 92.2 86.4 94.1
(Glu101)O−Mn−O(Wat1) 100.9 98.5 99.0
(Glu101)O−Mn−O(Wat2) 88.5 90.4 90.5
(His95)N−Mn−N(His97) 95.8 92.8 95.2
(His95)N−Mn−N(His140) 82.4 86.7 83.1
(His95)N−Mn−O(Wat1) 85.0 92.6 84.0
(His95)N−Mn−O(Wat2) 86.7 92.0 87.2
(His97)N−Mn−N(His140) 90.4 103.2 90.6
(His97)N−Mn−O(Wat1) 85.2 86.1 84.3
(His97)N−Mn−O(Wat2) 175.4 166.4 175.6
(His140)N−Mn−O(Wat1) 166.2 169.7 165.6
(His140)N−Mn−O(Wat2) 93.8 90.0 93.3
(Wat1)O−Mn−O(Wat2) 91.2 81.1 92.4
Mn−O(Glu280) 2.05 2.07 2.10
Mn−N(His273) 2.46 2.27 2.33
Mn−N(His275) 2.30 2.25 2.43
Mn−N(His319) 2.41 2.25 2.33
Mn−O(H) 2.00 2.19i 1.98
(Glu280)O−Mn−N(His273) 163.6 173.2 157.0
(Glu280)O−Mn−N(His275) 81.1 85.0 75.8
(Glu280)O−Mn−N(His319) 98.5 98.9 97.0
(Glu280)O−Mn−O(H) 116.0 90.2 116.8
(His273)N−Mn−N(His275) 83.7 88.5 81.5
(His273)N−Mn−N(His319) 78.2 85.1 82.6
(His273)N−Mn−O(H) 79.7 94.3 86.0
(His275)N−Mn−N(His319) 100.2 109.2 98.8
(His275)N−Mn−O(H) 139.7 148.5 158.5
(His319)O−Mn−O(H) 111.7 102.3 96.7
aBond lengths (Å) and angles (°). bQM/MM-optimized structure with the bound hydroxide in the C-terminal Mn(II) center forming a hydrogen
bond to a water molecule. This structure was obtained from the X-ray crystal structure of WT OxDC (1UW8) (Figure 7a,d). cQM/MM-optimized
structure with water bound to the C-terminal Mn(II) center based on the X-ray crystal structure (1UW8) (Figure 7b). dQM/MM-optimized
structure with hydroxide bound to the C-terminal Mn(II) center based on the X-ray crystal structure (1UW8) (Figure 7c). eQM/MM-optimized
structure obtained from the X-ray crystal structure of the Co(II)-containing W132F OxDC variant. fQM/MM-optimized structure obtained from in
silico substitution of the X-ray crystal structure of WT OxDC (1UW8). gBacillus subtilis residue numbering. hNot applicable. iMn(II)-bound water.
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in biomolecular systems for which only lower-resolution crystal
structures are available.
■ CONCLUSIONS
In addition to resolving the question of Mn(II) assignments for
OxDC, this study provides further evidence for the utility of
advanced quantum mechanical calculations in probing the
electronic structure of protein-bound metal centers. To date,
there have been few such calculations, in part because previous
efforts to compute zfs parameters on a series of Mn(II)-
containing complexes gave large differences between theoret-
ically predicted and experimentally measured values. These
discrepancies can be attributed to the high sensitivity of the zfs
parameters to the geometrical features of the structures used for
the calculations. It is also true that the requirement that zfs
parameters reflect only small energy differences places
considerable demands on the computational methods used to
obtain them, and only a qualitative agreement giving rise to
correct trends can be expected in general. On this point, we
note that the overestimated D values found in efforts to
compute the zfs parameters for the Mn(II) ions bound to
enolase14 were attributed both to the high sensitivity of the
calculated values to the molecular geometries employed and the
use of DFT calculations instead of correlated ab initio methods.
However, some of the limitations associated with the use of
DFT methodologies might be overcome by employing the
more recently developed coupled-perturbed spin−orbit cou-
pling (CP-SOC) formalism (as used here) instead of the
Pederson and Khanna (PK) approach used in the previous
work on enolase-bound Mn(II) ions, provided that the direct
spin−spin interaction is properly included in the treatment. In
particular, systematic investigation of the ability of coupled-
perturbed DFT methodologies to estimate zfs parameters in
Mn(II) transition metal complexes15 also showed that reliable
results could be obtained using a hybrid DFT functional
(B3LYP) if accurate geometries were employed.
The theoretical results reported herein, however, demon-
strate that the use of a strategy based on computation of zfs
parameters at the DFT theory level for cluster models obtained
from QM/MM-optimized structures has some value, especially
if high-quality X-ray structures are available for the protein, or
site-specific variant, of interest. Indeed, the reorientation of the
His-97 side chain observed upon the application of our
computational protocol was likely an essential element in
obtaining good agreement between the calculated and
experimentally observed zfs parameters. Our results also show
that QM/MM-optimized models of variant structures can also
yield qualitatively correct changes in computed zfs values,
especially when the site-specific mutation does not introduce
large structural changes in the metal ion environment.
Presumably this reflects the ability of carefully equilibrated
QM/MM structures to capture the critical metal−ligand
interactions, such as metal−ligand distances and coordination
geometries, needed to obtain good estimates of zfs parameters.
Although additional systematic computational investigations on
the problem of computing zfs values are clearly needed, our
findings set the scene for theoretical studies aimed at
delineating the effect of active site modifications on the
electronic structure of the metal centers in OxDC and, perhaps,
other Mn-dependent enzymes.
■ EXPERIMENTAL SECTION
Expression, Purification, and Kinetic Characterization of WT
OxDC and the Mn(II)- and Co(II)-Containing W132F OxDC
Variants. Unless otherwise stated, all chemicals were purchased in the
highest purity from Sigma (St. Louis, MO) or Fischer Scientific
(Pittsburgh, PA). Nickel-nitrilotriacetic acid agarose (Ni-NTA) was
obtained from Qiagen (Germantown, MD). Protein concentrations
were determined using the Bradford assay (Pierce, Rockford, IL).23 All
DNA primers were obtained from Integrated DNA Technologies, Inc.
(Coralville, IA), and DNA sequencing was performed by the core
facility in the Interdisciplinary Center for Biotechnology Research at
the University of Florida. ICP-MS determinations of metal content
were performed at the University of Georgia Center for Applied
Isotope Studies Chemical Analysis Laboratory (Athens, GA). The
gene encoding the W132F OxDC variant was constructed by overlap
extension (see Supporting Information).24 The recombinant His6-
tagged Mn(II)-substituted W132F OxDC variant was expressed and
purified following published procedures,8a except that expression was
induced in the presence of 5 mM MnCl2 after heat shocking the
bacteria for 12 min at 42 °C with constant agitation. After the addition
of IPTG, the cultures were incubated at 37 °C for 4 h before being
harvested by centrifugation at 2000g for 20 min (4 °C). After
sonication in lysis buffer, the resulting supernatant was centrifuged at
20 000g for 20 min (4 °C) before the enzyme was purified from the
cleared lysate by metal affinity chromatography on a Ni-NTA column.
The eluted protein was then subjected to dialysis at 4 °C to give a
solution in 50 mM Tris buffer containing 500 mM NaCl, pH 8.5.
Samples used for EPR analysis were incubated with Chelex resin
before being concentrated to 27 mg/mL using an Amicon Centriprep
YM-30 filter unit from Millipore (Billerica, MA). The catalytic
properties of the His6-tagged Mn(II)-containing W132F OxDC variant
were determined by measuring formate production using an end-point
assay as described elsewhere.6a Measurements were made at specific
substrate and enzyme concentrations in triplicate, and the data were
analyzed to obtain the values of V and V/K by standard computer-
based methods.25 His6-tagged Co(II)-containing W132F OxDC was
expressed as described previously with the addition of 2 mM CoCl2
after heat shocking the cells at 42 °C for 18 min. Cells were lysed using
a microfluidizer, and the mixture was clarified by centrifugation at 38
000g for 30 min. The soluble protein was then purified using a Talon
cobalt column. The eluate was dialyzed overnight in the storage buffer
(50 mM Tris-HCl, pH 8.5, and 500 M NaCl), and the protein was
then further purified on a 320 mL sephacryl S-100 gel filtration
column.
Figure 9. Superimposition of the cluster models used to calculate the
zfs parameters of the Mn(II) N-terminal binding site in the W132F
OxDC variant. Color scheme: green, initial structure based on the X-
ray crystal structure of the Co(II)-containing variant; orange, initial
structure derived from the X-ray crystal structure of WT enzyme (in
silico substitution). Figure rendered using VMD.11
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X-ray Crystal Structure of the Co-Substituted W132F OxDC
Variant. Purified Co(II)-containing W132F OxDC was concentrated
to 5 mg/mL in 100 mM Tris-HCl, pH 8.5, containing 500 mM NaCl.
Crystals were obtained by the vapor diffusion method with hanging
drop geometry by mixing protein (2 μL) and well solution (2 μL). The
well solution contained 100 mM Tris-HCl, pH 8.5, 2 M NaCl and 10%
PEG 6000. Crystals, which were rectangular prisms (0.3 × 0.2 × 0.2
mm), appeared in approximately 2 months at 17 °C and were cryo-
protected in well solution containing 25% glycerol and flash frozen in
liquid nitrogen. The Co(II)-substituted W132F variant crystallized in
space group R32 with unit cell dimensions a = b = 156.973 Å and c =
330.473 Å. Data were collected to 1.9 Å resolution at the National
Synchrotron Light Source (NSLS), Brookhaven National Laboratory
(Upton, NY), at beamline X25 equipped with a Pilatus 6M detector
(Table 3). Phasing was achieved by molecular replacement26 (Phaser-
MR in the Phenix software suite27) using the model of formate-
containing WT OxDC (PDB 1J58)10b after removal of all ligands. The
structure was refined using alternating rounds of manual rebuilding in
COOT28 followed by minimization in PHENIX to give a final model
that contained residues 6−382 with 4 molecules in the asymmetric
unit, 1228 waters, and 8 Co(II) ions. The model was refined to 2.1 Å
resolution with a Rwork and Rfree of 19.6 and 22.7%, respectively (Table
3). The Ramachandran plot shows that 97.6% of residues fall in the
most favored regions with 2.3% in the allowed regions. The maximum
likelihood coordinate error is 0.23 Å, consistent with accurate
coordinates. Coordinates and structure factors for the Co(II)-
containing W132F variant have been deposited in the PDB with
accession code 4MET.
EPR Studies of WT OxDC and the W132F OxDC Variant.
High-field EPR spectra at 324.6 GHz were recorded at the National
High Magnetic Field Laboratory (NHMFL), using a homodyne
transmission-mode spectrometer with a nonresonant probe and a 17 T
superconducting magnet.29 WT OxDC (27 mg/mL; 1.4 Mn/
monomer) or the W132F OxDC variant (40 mg/mL; 1.6 Mn/
monomer) was dialyzed into 50 mM Tris, pH 8.5, containing 500 mM
NaCl. Approximately 200 μL of this solution was placed into a Teflon
cup with 7.2 mm i.d. and placed into the FIR beam of the
spectrometer at 4 K, as measured using a built-in carbon-glass
temperature sensor in the cryostat. A Cernox sensor was used to map
out the temperature scale at the sample position to correct for any
temperature gradient in the cryostat. Spectra were taken with a
modulation amplitude of approximately 27 G at a modulation
frequency of 30 kHz using a phase-sensitive lock-in detector with
the time constant set to 300 ms. Field scans were taken with a sweep
speed of 2 mT/s. The spectra were simulated based on the usual spin
Hamiltonian (shown below) using the EasySpin toolbox for Matlab.30
μ̂ = ̂ · ̂ − ̂ ̂ + + ̂ · ̂ − ̂ · ̂ + · ̂
+ ·̂ ̂
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MD Simulations. MD simulations of the wild-type form of OxDC
were based on the 1UW8 crystal structure of the enzyme. Two
different procedures were employed to build the W132F OxDC
variant: (i) in silico mutation, manually substituting Trp-132 by Phe in
the 1UW8 X-ray structure, and (ii) replacement of Co with Mn using
the Co-substituted W132F OxDC mutant as template. In every case,
the initial structure was immersed in a periodic box of approximately
77 × 118 × 87 Å3 containing about 22 500 water molecules and
neutralized with Na+ counterions. The box dimensions were chosen to
achieve a minimum distance of 30 Å between two periodically
replicated images of the protein. The all-atom AMBER03 force field31
was used to model protein residues and ions, whereas the TIP3P
model32 was employed for water molecules. All potentially charged
amino acids, including the C- and N-termini, were considered to be in
their default protonation states at physiological pH (i.e., charged).
Electrostatic interactions were taken into account using the particle
mesh Ewald algorithm33 with a real space cutoff of 10 Å. The same
cutoff was employed for the treatment of the van der Waals
interactions. Bonds involving hydrogen atoms were constrained
using the SHAKE algorithm.34 An integration time step of 2 fs was
used. Constant temperature (300 K) and pressure (1 atm) were
achieved by coupling the systems to a Langevin thermostat and a
Nose−́Hoover Langevin barostat, respectively.35,36 Systems were first
minimized using a conjugate gradient algorithm and then heated to
300 K in 600 ps while keeping positional restraints on protein heavy
atoms. For each system, an initial run of 5.4 ns in the NPT ensemble,
slowly removing the restraints, was followed by a subsequent 20 ns
simulation in the canonical (NVT) ensemble in order to provide
starting configurations for the subsequent QM/MM optimizations. All
the classical MD simulations were carried out using the NAMD
package.37
QM/MM Geometry Optimizations. QM/MM geometry opti-
mizations were performed starting from equilibrated configurations
taken from the aforementioned classical runs. The quantum
mechanical/molecular mechanical (QM/MM) implementation em-
ployed combines the use of the QM program QUICKSTEP38 and the
MM driver FIST, both part of the CP2K package (freely available at
http://cp2k.berlios.de, released under GPL license). In this code, the
general QM/MM scheme is based on a real-space multigrid technique
to compute the electrostatic coupling between both QM and MM
regions.39,40 In all the optimizations, a quantum region consisting of
the Mn center together with the residues at a distance shorter than 6 Å
from it (including only the side chains up to the Cβ atom) was treated
at the density functional theory level, whereas the remaining part of
the system, including water molecules and counterions, was modeled
at the classical level using the AMBER force field to take explicitly into
account the steric and electrostatic effects of the surroundings. The
valence of the terminal QM atoms was saturated by the addition of
capping hydrogen atoms. A dual basis set, Gaussian and plane-wave
formalism, was employed to compute the interaction energy within the
QM subsystem. A molecularly optimized double-ζ valence basis set
Table 3. Crystallographic Data and Refinement Statisticsa
data Collection refinement
resolution (highest resolution shell) (Å) 47.39−2.095 (2.17−2.095) protein residues/water molecules per asu 1508/1228
X-ray source X25, NSLS other ligands per asu 8
wavelength (Å) 0.979 reflections (work/free) 91562/1997
space group R32 Rwork/Rfree (%) 19.6/22.7
cell dimension (Å) a = b = 156.97, c = 330.47 resolution (Å) 49.06−2.09
reflections observed (unique) 177937 (91647) average B-factor (Å2)
completeness (%) 99.7 (100) protein (Å2) 23.15
Rmerge (%)
b 14.7 (29.2) Co(II) (Å2) 17.55
I/σ (I) 3.3 (2.56) water (Å2) 21.02
redundancy 19.1 (13.2) rmsdc bond lengths (Å) 0.008
rmsd bond angles (°) 1.113
aData for the highest resolution shell is in parentheses. bRmerge =∑hkl∑i|Ihkl,i − ⟨Ihkl⟩I|/∑hkl∑i|Ihkl,i |, where ⟨Ihkl⟩ is the mean intensity of the multiple
Ihkl,i observations for symmetry-related reflections.
cRoot-mean-square deviation.
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augmented with polarization functions (m-DZVP) was used41 to
describe the wave function, while an auxiliary plane-wave basis set
expanded up to a density cutoff of 360 Ry was utilized to converge the
electron density in conjunction with Goedecker−Teter−Hutter
pseudopotentials42,43 to describe the core electrons. Exchange and
correlation energies were computed within the generalized gradient
approximation by using the BLYP functional.44,45
Zero-Field Splitting Calculations. The calculation of the SOC
and SS parts of the zfs parameters was performed with the ORCA
electronic structure package.46 We performed these calculations on
cluster models, in which only the OH/H2O molecules in the active site
cavity and the side chains of all the residues in the first coordination
sphere around the metal were included. DFT-based zfs parameters
were computed for these models using the hybrid B3LYP25 functional
in conjunction with triple-ζ (def2-TZVP) valence basis sets,47 taking
advantage of the RIJCOSX approximation48 to speed up the
calculations. In all cases, tight SCF convergence criteria were
employed. The coupled-perturbed SOC approach was used to evaluate
the DSOC contribution, whereas the DSS contribution was obtained on
the basis of the spin-unrestricted natural orbital determinant.49 Scalar
relativistic effects were taken into account by means of the van
Wüllen’s model potential approximation to the ZORA equations.50
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5. Future Directions for Oxalate Decarboxylase
It is clear from the experiments discussed in Chapter 4 that multiple oxidation states
of Mn appear to be present in Oxalate Decarboxylase. Further work may help us
to understand which site has which oxidation state, whether this oxidation state ex-
clusive to the site, what oxidation state gives chemistry, and if any oxidation states
prevent chemistry. Central to this question is the issue of whether the sites are
formally coupled. In this chapter, I discuss some further experiments that may il-
luminate the answers to these questions in the context of other Mn metalloenzyme
systems.
5.1 Dependence of Oxalate Decarboxylase on Mn
Some ”famous” Mn enzmyes such as Superoxide Dismutase and Ribonucleotide
Reductase are not strictly Mn-dependent for activity. In the case of Superoxide Dis-
mutase, there are at least three forms of the protein, all accepting different metals, but
even the SOD which takes Mn primarily can take Fe (albeit with a reduced activity).
Oxalate Decarboxylase is not like this- it must incorporate Mn, and is inactive when
any other metals are primarily substituted. This places Oxalate Decarboxylase in the
company of the catalases and arginases. Catalases and Arginases each uncouple the
net reaction into two half reactions, with electron and proton storage between the
redox steps. It is possible to imagine such reactions in the case of Oxalate Decar-
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boxylase, although this does not directly answer the role of propagation by the metal
center in these half reactions:
C2HO4 → C2O4 +H+ + e− (5.1)
H+ + e− + C2O4 → CO2 +HCO2 (5.2)
5.2 Oxalate Decarboxylase Reduction Potential of Manganese
EPR studies indicate that there is both Mn2+ and Mn3+ present in the enzyme
variants W132F and Q282W, but no Mn(III) in the WT enzyme. The inability to see
Mn(III) in WT OxDc could be a limitation of the parallel-mode EPR implimentation,
so for the sake of argument let us assume that the relationshiop of the concentration

























Let us compare the activity of these proteins. Let us refer back to date from Chapter
5 (Table 5.1). The Q282W protein is the most active, and has the most amount of
Mn3+. It is first tempting to consider the fact that Mn(III) is the necessary catalytic
metal in general, but then it is immediatly evident that WT, with seemingly no
Mn3+, is more active than W132F, with some amount of Mn3+. So, a simple linear
relationship between Mn3+ and activity is not immediatly evident. Then one can
consider that there are two active sites. Perhaps, like in Manganese Catalase, there is
catalytic relevance only when both Mn are matched in oxidation state. So, perhaps
WT has two Mn in Mn2+ form, W132F is a mixed state of Mn2+ and Mn3+, and
Q282W has two Mn Mn3+ form. This argument is plausible regardless of which
active site does chemistry, or if both sites do chemistry, which is another argument
entirely. Let us assume that the most active form of the enzyme is with Mn3+. When
we reconsitute the enzyme with Mn2+ (in the form of MnCl2,) we may be producing
a less active form of the enzyme than if we were able to reconsitute with Mn3+, which
is not possible in an aqueous environment due to stability problems. Perhaps the
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Q282W mutation is forcing the enzyme to assume the Mn(III) (more favorable for
catalysis) oxidation state. One can imagine that the tryptophan hydrogen bonding
with the metal binding Glutamate in the C-terminus would be able to pull electron
density from the metal site through stabilization of this glutamate residue.
Table 5.1.
Tryptophan Steady-state Kinetic Data
Protein KM Kcat/KM/Mn Metal Mn
3+?
WT 2±1 9000±100 Mn none
W132F 50±5 700±100 Mn some
Q282W 3±1 15000±400 Mn,Mg a lot
One may make the argument that the calculations shown in Chapter 4 (repro-
duced here as Table 5.2, indicate that there is no change in the C-terminus as a
function of the N-terminus. However, it is important to note that these calculations
were produced from two active site that are not joined with QM. Otherwise, only
electrostatic interactions might be replicated in the C-terminus as an effect of the
change to the N-terminus by the W132F mutation. The proper calculation, and I
believe, one that would show significantly more change to the C-terminus as a func-
tion of W132F. The approach was adequate to differentiate between the two sites,
which was the initial point. But further approaches need to account for much smaller
changes to the C-terminus as a function of change in the N-terminus.
It is worth noting here that calculations suggest that D values may be as large
as 100,000 MHz when Mn(III) is substituted into the N-terminus. In this case, we
will never be able to directly see fine structure regarding Mn(III) for HF-HF EPR,
but instead will need to rely on Parallel-mode low frequency methods to deduce any
information regarding Mn(III) species.
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Table 5.2.
Experimental and Calculated Fine Structure Parameters for OxDc
Protein source site D(MHz) E/D
WT experimental ”I” -1350 0.15
WT DFT/MM-optimized N-terminal -1170 0.11
WT experimental ”II” 10430 0.20
WT DFT/MM-optimized C-terminal 4110 0.22
W132F experimental ”I” -1950 0.21
W132F DFT/MM optimized N-terminal -2100 0.23
W132F experimental ”II” 10430 0.20
W132F DFT/MM optimized C-terminal 4110 0.22
5.3 Oxalate Decarboxylase Dependence on Quaternary Structure
Interestingly, many of the strictly Mn-dependent enzymes are in fact binuclear
Mn enzymes. Otherwise, the interplay of two Mn ions can not be replicated by the
presence of another metal. With a 20 A˚ separation between the two active sites, it
seems formally impossible to consider this system to be a binuclear system, but in fact
there are several characteristics that suggest that this behavior is not outside the realm
of possibilty. Figure 5.1 shows the shortest pathway between the two Mn of OxDc,
which is interestingly not within the monomer itself but between adjacent monomers
(perhaps lending evidence to the necessity of at mininal, the trimeric interface, to
remain intact for catalysis.)
Preliminary ultracentrifugation experiments suggest that the protein can be found
in a variety of quaternary configurations, all within multiples of three (trimer, hex-
amer, nonamer, dodecamer, etc.) in solution, and that these relationships are not pH
dependent but may be concentration dependent. [77] This initially may suggest that
the trimer, and not the hexamer is biologically relevant. But, this seems to combat
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Figure 5.1. Shortest path between two Mn centers (purple) with Site-
1 as the N-terminus and Site-2 as the C-terminus. Reproduced in
edited form, with permission. [58])
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the observation that the hexamer is actually two trimers that have been arranged in
a sandwhich style, such that the active sites found in each trimer are closest to each
other. Otherwise, there is no apperent way that a structure such as a nonamer could
exist (at least in an energetically favorable conformation). What face would the third
trimer bind to on the hexamer, and why would it not recruit another trimer in order
to enjoy the binding energy that would be gained from forming the dodecamer?
Calculations are currently underway to assess the true nature of the binding at the
trimer-trimer interface. It is true that no directly electronic contributions have been
postulated between one trimer and another trimer. Nor is it likely that communication
exists directly between the Mn of separate trimers, although this is not impossible,
especially if we are postulating that Mn of adjacent monomers may have interaction
via tryptophan side chains.
5.4 Probing the Connectivity of the Active Sites
An interesting core of tryptophans is found at the interface of each monomer.
In this trytophan core, there are two pairs of tryptophans, with a donor from each
monomer to each pair. In Figure 5.2 it is clear that W96 and W274 overlap in a pi-
stacking interaction. When this interaction is reduced (but not ameliorated) by the
mutation W96F, there is both an interesting affect on the catalytic activity (significant
reduction) but also a change in the association of the monomers on an SDS-PAGE gel
(Figure 5.3). This mutation appears to stablize the trimer, and possibly the dimeric
oligomerizations. Current calculations are underway to try to understand this phe-
nomenon, but it could be loosely conjectured from these two pieces of evidence that
(1) this interface is necessary for catalysis, and perhaps there is some radical pathway
which works by way of tryptophan residues, and (2) this mutation has mechanically
strengthed the bonding at this interface (perhaps the pi-stacking interaction was actu-
ally improved by this mutation, or, the interaction at the residue interface is weaker
which is allowing for flexibility in the protein that is strengthening the interaction be-
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Figure 5.2. Trytophans at the Monomer:Monomer Interface
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Figure 5.3. W96F SDS-PAGE gel
tween the two domains. As a fimal comment regarding Figure 5.3, it is clear that the
W96 mutant shows two dimer-sized bands which resolve slightly differently. These
could be dimers of slightly different orientations (perhaps the monomers are meeting
at slighly different angles and therefore the more linear arrangment moves more slowly
than a more bent arrangment), or, this could be representative of a dimer between
interfacing monomers as well as a dimer of stacked monomers. Further investigation
of this phenomenon is of interest.
5.5 Recommendations for Future Experiments
Akin to the issues raised in this chapter are several experimental directions that
may provide additional information to solve these problems. First, more mutants
that modulate the oxidation state of the active-site metals would be extremely use-
ful. For example, the EPR of W96F, W171F, W274F, W348F and combinations
of these mutations, would be very useful to modulate the shortest-possible path be-
tween adjacent monomer metal-sites. Second, although fine structure determination
through EPR is extremely limited to only the low D value parameters generated
from Mn2+ species, EXAFS may make accessible higher D value Mn3+ manifolds for
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analysis. Excitingly, EXAFS also can unveil non-formal oxidation states, such as the
state Mn3.5+ in the OEC of PSII, a phenomenon which is not out of the question for
Oxalate Decarboxylase. Additionally, MCD may be the best method for analyzing
the quantitative amount of different oxidation states. Although preliminary MCD
experiments have been done to qualitatively mention these oxidation states, further
quantitative analysis of the currently known and other mutants will be of interest.
Also, although it is known that WT OxDc does not use Iron for catalysis, it is not
known if the other mutants can use Iron (or other transition metals). This should
be investigated as this is a common theme in tightly bound Mn enzymes as well as
dinuclear Mn enzymes. Further, O2 is not consumed in this reaction, but oxygen
appears to be necessary for catalysis. It would be very useful to search for this bind-
ing site. It is already clear that the triplet oxygen is not interacting with a metal
(based on EPR studies) but site directed mutagenesis to tyrosine and tryptophan
residues may find the binding location of oxygen (and unveil an oxygen binding site
to metal-binding-site radical pathway). Additionally, the occurence of the 1:1 Mg:Mn
ions in the Q282W protein is curious. It is possible that there is a Mg2+ binding site
in this protein with some structural role. Although it is not possible to probe for Mg
through most spectroscopic methods, Mg ligation could be considered as a way to
solidify the trimeric-interaction, and should be a standard metal for which we search
during all metal analysis experiments. Finally, A tryptophan radical was evidenced
in early W132F work. The only tryptophans that would be proximal enough to the
metal-site to produce such a signal are the W96 and W274 residues. Futhermore,
these residues are not the source of a radical in the WT protein (in this case it is
a Tyrosine radical instead). This radical should be further investigated through the
freeze-quench EPR analysis of slow mutants (and this technique could be broadly
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CONTRIBUTIONS (LECTURES, ABSTRACTS AND POSTER PRESENTATIONS) 
25. (Invited Lecture) The Interface of Physics, Chemistry and Biology:  Paired Computational 
and Experimental Investigations into Biological Macromolecules.  Michigan State University, 
East Lansing, MI, USA.  April 22, 2014. 
 
24. (Invited Lecture) Modeling the Phosphoryl Transfer Transition State in the Oncogenetically 
Indicated GTPase protein RhoA and it’s Activating Protein RhoA.GAP.  University of London, 
London, UK.  November 29, 2013. 
 
23. (Invited Lecture) Mechanistic Studies of the Coenzyme B12-Dependent Methylmalonyl-
CoA Mutase.  Florida Inorganic and Materials Symposium, University of Florida, Gainesville, 
Fl, USA.  October 18-19, 2013. 
 
22. (Contributed Lecture) Structural element that controls the redox preferences of the active site 
manganese in oxalate decarboxylase.  ACS National Meeting, Indianapolis, IN, USA. September 
11, 2013. 
 
21. (Invited Lecture) Oxalate Decarboxylase: Incorporating fluorinated amino acids and point 
mutations to identify hydrogen bonding interactions that contribute to the catalytic prowess of 
the active site Manganese ion.  University of Kentucky, Louisville, KY, USA.  August 27, 2013. 
20. (Contributed Lecture) Computational, Structural, and Kinetic Evidence that Vibrio vulnificus 
FrsA is not a Cofactor-Independent Pyruvate Decarboxylase. 4th Annual Southeast Enzyme 
Conference, Georgia State University, Atlanta, GA, USA. April 20, 2013.  
 
19. (Contributed Lecture) Redox Chemistry in the Manganese Dependent Enzyme Oxalate 
Decarboxylase. Florida Inorganic and Materials Symposium, University of Florida, Gainesville, 
FL, USA. September 28-29, 2012.  
 
18. (Contributed Lecture) The Effect of SKCa and IKCa Activation with the Novel Drug NS309 
on Smooth Muscle Contractile Nature in Rat Urinary Bladder. Howard Hughes Undergraduate 
Research Scholars Symposium, University of South Carolina, SC, USA. August 9, 2007. (pp. 
108-119.)  
 
17. (Contributed Abstract and Scimix Selected Poster) Computational Evidence for a 
“Metaphosphate” Transition State, as Predicted by Phosphate Analog Crystallization Studies, in 
the Oncogenetically Indicated GTPase protein RhoA and it’s Activating Protein RhoA.GAP.  
ACS National Meeting, Computers in Chemistry poster session, Dallas, TX, March 15-20, 2014. 
 
16. (Contributed Abstract and Poster) Mechanistic Studies of the Coenzyme B12-Dependent 
Methylmalonyl-CoA Mutase.  Biophysical Society Annual Meeting, San Francisco, CA, 
February 15-19, 2014. 
 
15. (Contributed Abstract and Poster) Modeling Phosphoryl Transfer in the Oncogenetically 
Indicated GTPase protein RhoA and it’s Activating Protein RhoA.GAP.  Biophysical Society 
Annual Meeting, San Francisco, CA, February 15-19, 2014. 
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14. (Contributed Abstract and Poster) Single-point Mutation Modulates Manganese Electronic 
Properties and Converts a Non-Catalytic Site to a Catalytically Relevant Active Site.  Midwest 
Enzymes Conference, Loyola University, Chicago, IL, October 12, 2013. 
 
13. (Contributed Abstract and Scimix Selected Poster) Computational evidence that Vibrio 
vulnificus FrsA is not a cofactor-independent pyruvate decarboxylase.  ACS National Meeting, 
Computers in Chemistry poster session, Indianapolis, IN, September 9-11, 2013. 
 
12. (Contributed Abstract and Poster) Computational, Structural, and Kinetic Evidence that 
Vibrio vulnificus FrsA is not a Cofactor-Independent Pyruvate Decarboxylase. 53rd Sanibel 
Symposium, St. Simons Island, GA. February 17-22, 2013.  
 
11. (Contributed Abstract and Poster) Pertubation of the N-terminal Mn(II) center in Oxalate 
Decarboxylase by Second-Shell Residue Mutation. Nucelic Acid Enzymes and Enzymes in 
Human Disease, Nankai University, Tianjin, China, June 19-24, 2011.  
 
10. (Contributed Abstract and Poster) Coetaneous Computational and Experimental Methods 
for Manganese Fine Structure Determination in Oxalate Decarboxylase. Florida Inorganic and 
Materials Symposium, University of Florida, Gainesville, FL October 22, 2011.  
 
9. (Contributed Abstract and Poster) Active Site Motion and Catalysis in Formyl-
CoA:Oxalate CoA Transferase. Celebrating Computational Biology meeting St. Catherine’s 
College, Oxford, UK, September 12-15, 2010.  
 
8. (Contributed Abstract and Poster)  Role Of Ca2+-Activated K+ Channel in the 
Neurogenic Contractions Induced by Electrical Field Stimulation in Detrusor Smooth Muscle 
Isolated from Rats and Guinea Pigs. Biophysical Journal, vol. 98, issue 3, pp. 125a-126a. 
 
7. (Contributed Abstract and Poster)  SK and IK Ca2+-activated K+ channels as novel 
pharmacological targets to control urinary bladder smooth muscle excitability and contractility. 
The FASEB Journal. 2008;22:1201.19. 
 
6. (Contributed Abstract and Poster) Stromatoxin-1-sensitive voltage-gated K+ channels 
regulate rat urinary bladder smooth muscle contractility. 2009 Annual Experimental Biology 
meeting New Orleans, Louisiana, April 18-22, 2009. 
 
5. (Contributed Abstract and Poster) The large conductance Ca2+- and voltage-activated K+ 
channel is the primary K+ channel that controls cell excitability and contractility in human 
urinary bladder smooth muscle. 2009 Annual Experimental Biology meeting New Orleans, 
Louisiana, April 18-22, 2009. 
 
4. (Second place poster award winner) SK and IK Ca2+-activated K+ channels as novel 
pharmacological targets to control urinary bladder smooth muscle excitability and contractility. 




3. (Contributed Abstract and Poster)  SK and IK Ca2+-activated K+ channels as novel 
pharmacological targets to control urinary bladder smooth muscle excitability and contractility. 
FASEB Experimental Biology, San Diego, CA, USA, April 5-April 9, 2008. pg. 427 (1201.19). 
 
2. (Contributed Abstract and Poster)  Functional and electrophysiological identification of 
large conductance voltage- and Ca2+-activated K+ (BK) channels in human urinary bladder 
smooth muscle. FASEB Experimental Biology, San Diego, CA, USA, April 5-April 9,2008. pg. 
427 (1201.20)  
 
1. (Contributed Abstract and Poster)  Stimulation of B3-adrenoreceptors activates 
spontaneous transient outward BK currents and causes relaxation in rat urinary bladder smooth 
muscle. FASEB Experimental Biology, San Diego, CA, USA, April 5-April 9, 2008. pg. 427 
(1201.18) 
